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ABSTRACT 
 
 
In order to respond to the need for hazard assessment of environmentally relevant 
pharmaceutical mixtures, 21-d life cycle tests were performed on a mixture of pharmaceuticals 
found in the Tennessee River using Daphnia- magna as a surrogate.   Endpoints measured were 
time to first brood, reproduction, mortality, and number of neonates produced per adult 
reproduction day. Reproduction was the only endpoint that showed a significant effect.  The 
LOEC of the pharmaceutical mixture was found at 100 times (100x) greater concentration 
(p=0.005) than what was detected in the Tennessee River.  Similarly, the NOEC was 75x 
(p=0.150).  Single concentrations of pharmaceuticals within the mixture up to the LOEC were 
found to have no effect.  Thus, no single pharmaceutical was responsible for the mixture LOEC.  
To determine if chitobiase can be used to predict secondary production, chitobiase activity and 
zooplankton density and biomass samples were measured in six Tennessee River tributaries.   
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CHAPTER I 
INTRODUCTION 
 
 
Pharmaceuticals in the Environment 
 
 Awareness of pharmaceuticals in the environment has grown over the past years due to 
the frequent detection in surface waters worldwide. Studies have been conducted in several 
countries including, Australia, Brazil, England, and the United States.  Through these studies, 
there have been more than 160 drugs detected in aquatic environments at concentrations in the 
ng/L to μg/L range (Costanzo, Murby, & Bates, 2005; Heberer, 2002; Kolpin et al., 2002; 
Stumpf, Ternes, Wilken, Rodrigues, & Baumann, 1999; Ternes, 1998; Ternes, Andersen, 
Gilberg, & Bonerz, 2002) Note: possibly use semicolons between authors and arrange citations 
by date throughout.  Because pharmaceuticals are designed to be biologically active, they have 
the potential to affect a large variety of non-target organisms through a variety of physiological 
consequences.  
Pharmaceutical production in most developed countries continues to increase.  Some 
individual drugs are used in quantities of 100 tons or more per year;  per capita estimates range 
from between 50 and 150 grams per year (Nikolaou et al., 2007).  In the United States 
$220,388,509,960 was spent on prescription drugs in 2010.  Among all 50 states, Tennessee was 
ranked 4
th
 for total retail sales of prescription drugs in 2010 (Kaiser Family, 2011). Unless 
sewage treatment plants (STPs) are improved, increased pharmaceutical use will result in an 
increase in pharmaceuticals and their metabolites entering surface waters.  Because 
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pharmaceuticals are persistent organic compounds, they are also appearing in ground water 
(Ankley, Brooks, Huggett, & Sumpter, 2007; Nikolaou, Meric, & Fatta, 2007).  
 The major pathway for human pharmaceuticals entering the natural environment 
is STPs (Kummerer, 2001).  Human excreta (excreta includes both urine and excrement – the 
latter refers to waste eliminated from the bowels) is the primary source of pharmaceuticals 
entering STPs.   Many of the pharmaceuticals consumed by humans are not completely 
metabolized in the body. For example, 90 % atenolol and 15% of sulfamethoxale was shown to 
be excreted unchanged. (Hirsch, Ternes, Haberer, & Kratz, 1999; Huschek, Hansen, Maurer, 
Krengel, & Kayser, 2004).   Sometimes the pharmaceutical is only slightly transformed into 
conjugates with endogenous molecules.  Conjugates such as glucuronides, the most common 
conjugate pharmaceutical form, can easily be cleaved during sewage treatment and the original 
pharmaceutical can then be released into the aquatic environment (Cunningham, 2008; Ternes, 
1998).   The disposal of unused medication via the toilet or sink is common practice and thus 
another pathway for pharmaceutical to reaching STPs.  About one third of pharmaceuticals sold 
in Germany are disposed down the drain (Greiner & Ronnefahart, 2003).   
At the STP, sewage is treated by a variety of methods.  Following sufficient treatment 
(per environmental laws), the sewage effluent is directly discharge into surface waters.  Current 
environmental laws address many pollutants (e.g., turbidity, pH, thermal, and dissolved oxygen), 
but pharmaceutical parent compounds or metabolites are not addressed.  Hydrophilic, polar 
pharmaceuticals tend to pass through STPs  - typically designed to remove lipophilic pollutants. 
Horsing et al. (2011) investigated the sorption of 75 pharmaceuticals in STP sludge and found 
that only 15 of the active pharmaceutical ingredients show a high affinity for the sludge.  This 
creates a continuous release of pharmaceuticals into the aquatic environment.  Consequently, 
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pharmaceuticals are found in the aquatic environment at ng/L and g/L concentrations (Ashton, 
Hilton, & Thomas, 2004; Kolpin et al., 2002).   For example, Kasprzyk-Hordern (2008) detected 
47 pharmaceuticals in two English rivers.  The concentration of each pharmaceutical was found 
to increase at sampling points located downstream of the STP’s effluent discharge site.  
Conversely, STPs have also been shown to dilute the water column and as result pharmaceuticals 
were found at lower concentrations directly downstream (Conley, Symes, Schorr, & Richards, 
2008; Ellis, 2006).  
 
Hazard to Aquatic Organisms 
 
 The occurrence of pharmaceutical mixtures in surface water is well documented but 
studies are scarce regarding the potential effects on aquatic life.  Most of toxicity tests have been 
conducted on single pharmaceuticals.  Such tests on zooplankton and fish, have found that 
effects generally occur at concentrations above those found in surface waters (Brooks et al., 
2003; Cleuvers, 2003; Flaherty & Dodson, 2005; Henry, Kwon, Armbrust, & Black, 2004; 
Marques, Abrantes, & Goncalves, 2004; McKinley & Hazel, 1993; Metcalfe, Koenig, et al., 
2003).   
Pharmaceutical effects on aquatic organisms vary according to the compound and 
organism.  Pharmaceuticals have been reported to correlate with reduced brood sizes of the 
cladoceran Daphnia magna, a freshwater crustacean, as well as increase mortality at 
concentrations in the mg/L range for acute tests (Ferrari, Paxeus, Lo Giudice, Pollio, & Garric, 
2003; Henry et al., 2004; Henschel, Wenzel, Diedrich, & Fliedner, 1997; Isidori, Lavorgna, 
Nardelli, Pascarella, & Parrella, 2005; Kim et al., 2007).  When D. magna were exposed to 
pharmaceuticals for a 21-day period, effects on reproduction were seen in the mg/L and µg/L 
ranges (Minagh, Hernan, O'Rourke, Lyng, & Davoren, 2009; Park & Choi, 2008; Stanley, 
5 
 
Ramirez, Chambliss, & Brooks, 2007; Yamashita et al., 2006).  Fish such as the Pimephales 
promelas exposed to pharmaceuticals, have experienced a decrease growth at a concentration of 
51µg/L of fluoxetine (Payan & Girard, 1977; Stanley et al., 2007).  Concentrations of ibuprofen 
at 1µg/L have shown to change reproduction patterns in Oryzias latipes (Flippin, Huggett, & 
Foran, 2007).  Most ranges are magnitudes higher than the ng/L concentrations of 
pharmaceuticals observed in surface water (Ashton et al., 2004; Conley et al., 2008; Kolpin et 
al., 2002).  Thus, although eco-toxicity tests on pharmaceuticals have increased significantly in 
recent years, much more research is needed on individual pharmaceuticals and environmentally 
relevant mixtures of pharmaceuticals (Kolpin et al., 2002).   
The global detection of pharmaceuticals in surface water indicates the realistic hazard to 
aquatic organisms and food web dynamics by these substances must be studied.  Since multiple 
pharmaceuticals are being detected in surface water, there is a need to study the combined or 
synergistic effect of environmental relevant mixtures and concentrations to determine toxic 
thresholds to aquatic organisms. By determining the threshold of environmentally relevant 
mixtures, the risk that these pharmaceutical mixtures may pose to the environment will be 
determined more accurately.   
In 2008, thirteen pharmaceuticals were quantified in the Tennessee River and its 
tributaries, these pharmaceuticals ranged from from 0.0028 to 0.1757 g/l (Conley et al., 2008).  
Chapter II investigates the hazard of these ratios at increased concentrations by performing 
chronic life cycle toxicity test on the cladoceran Daphnia magna. 
 
Chitobiase as a Biomarker for Toxic Effect in Aquatic Environments 
It is common practice to assess a stream’s health by quantifying samples of benthic 
invertebrate populations.  However, this process takes many months to complete and is costly 
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due to the amount of labor that is involved in the process (Bailey, Norris, & Reynoldson, 2001; 
Hanson & Lagadic, 2005; Lenat & Resh, 2001).   A fast and inexpensive way to estimate the 
aquatic invertebrate population would create a way to gauge the arthropod community in a 
matter of hours or days (Hanson & Lagadic, 2005).  This method would allow for community 
changes to be observed almost instantaneously.  Chitobiase is one of two chitinolytic enzymes 
that are involved in the process of molting by invertebrates (Muzzarelli, 1977).  This enzyme is 
released into the water column and can be measured. Ambient concentration of this enzyme has 
the potential to symbolize total molting activity or biomass production of arthropod (Hanson & 
Lagadic, 2005; Sastri & Dower, 2009).  Laboratory and field studies have shown a correlation 
between chitobiase activity within the water column and aquatic invertebrate assemblages (Espie 
& Roff, 1995; Oosterhuis, Baars, & Breteler, 2000; Sastri & Dower, 2009).     
Ambient chitobiase has been measured in the Tennessee River and has been found to 
fluctuate with seasons (Conley, Schorr, Hanson, Symes, & Richards, 2009).  Seasonal variation 
in zooplankton populations have been recorded in temperate rivers (Tans, Mathoux, Grandjean, 
& Kestemont, 1998; Threlkeld, 1983). However, correlations between zooplankton populations 
and chitobiase concentrations in riverine ecosystems have yet to be confirmed.  To investigate a 
possible relationship between chitobiase activity in a riverine environment and zooplankton 
assemblage, six tributaries to the Tennessee River six creeks were sampled for three seasons; 
four of six tributaries were sampled for four seasons.  Chapter III reports the findings of this 
study. 
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CHAPTER II 
HAZARD ASSESSMENT OF A MIXTURE OF PHARMACEUTICALS  
FOUND IN THE UPPERTENNESSEE RIVER 
 ON DAPHNIA MAGNA 
 
Introduction 
 Pharmaceuticals found in aquatic environments over the past years have increasingly 
become a point of environmental concern. Pharmaceuticals can be human or veterinary 
therapeutics (Glassmeyer et al., 2005). Due to their physicochemical and biological properties, 
there is concern about the potential for their impacts on non-target species (Park & Choi, 2008).  
STPs are a major point source of these compounds.  As a result, pharmaceuticals reach surface 
water and sediments, causing concentrations ranging from ng/L to μg/L (Kummerer, 2001).  The 
natural environment has the potential to degrade pharmaceuticals by biotic and abiotic processes, 
but STPs may overwhelm these processes by continuously discharging pharmaceutical-laden 
effluent on a daily basis (Castiglioni et al., 2006; Vieno, Tuhkanen, & Kronberg, 2007).  The 
potential ecological significance of this continual discharge remains largely unknown (Sanderson 
et al., 2004).   
 Pharmaceuticals have been detected in surface water around the world including the 
Tennessee River (Buser, Muller, & Theobald, 1998; Conley et al., 2008; Kolpin et al., 2002; 
Kummerer, 2001).  In the UK, most STPs were found to routinely discharge low quantities of 
pharmaceuticals into lakes and rivers (Ashton et al., 2004).  Kolpin et al. (2002) sampled 139 
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streams and rivers around the U.S. and detected pharmaceuticals in 80% of those surface waters.  
A recent study examined a 295 km portion of the Tennessee River from Knoxville, TN to 
Chattanooga, TN, encompassing three STPs (Conley et al., 2008). That study found thirteen 
pharmaceuticals in the water column, with concentrations ranging from 0.0013 g/L to 0.1757 
g/L (Table 1). The Tennessee River watershed is ideal to study given that Tennessee ranks 4
th
 
in the nation for prescription drug use (Kaiser Family, 2011) and the river passes many of the 
most populated regions of Tennessee. 
 
Table 1   
 
Thirteen pharmaceuticals measured in the Tennessee River, listed by frequency of                                                                  
detection (Conley et al., 2008). 
 
  
Range Median Frequency 
(µg/L) (µg/L) (%) 
Caffeine 0.081-0.176 0.288 92.2 
Sulfamethoxazole 0.003-0.033 0.0079 85.9 
Carbamazepine 0.002-0.023 0.005 79.7 
Trimethoprim 0.002-0.006 0.0056 32.0 
Acetaminophen 0.002-0.012 0.0029 13.3 
Diltiazem 0.001-0.01 0.019 10.2 
Ciprofloxacin 0.004-0.054 0.0069 10.2 
Levofloxacin 0.006-0.059 0.0119 6.3 
Atorvastatin 0.003-0.101 0.0068 4.7 
Lovastatin 0.010-0.1029 0.0035 3.1 
Sertraline 0.002-0.012 0.0183 2.3 
Fluoxetine 0.003-0.0101 0.007 1.6 
Norfluoxetine 0.0028 - - 
 
 
 Ecological impacts of pharmaceuticals on non-target aquatic organisms have been 
investigated in the laboratory and to a lesser degree in the field.  Current literature on effective 
concentration (EC50), lethal concentration (LC50), no observed effect concentration (NOEC), and 
lowest observed effect concentration (LOEC) for individual pharmaceuticals found in the 
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Tennessee River on aquatic invertebrates are summarized in Table 2.   The pharmaceutical that 
has received the most attention is fluoxetine ((±)-N-methyl-3-phenyl-3-[4- (trifluoromethyl) 
phenoxy]propan-1-amine).  Fluoxetine is a serotonin re–uptake inhibitor (SSRI) and is one of the 
most acutely toxic pharmaceuticals reported for benthic invertebrates (Fent, Weston, & 
Caminada, 2006).  Kolpin et al. (2002) reported that fluoxetine concentrations averaged 0.012 
g/L in US streams.  Fluoxetine is primarily excreted by the human body as a glucuronide 
conjugate and as a result may be cleaved back to fluoxetine during treatment in STPs 
(Cunningham, 2008). Brooks et al. (2003) found bioaccumulation of fluoxetine in fish tissue.  
Pery et al. (2008) observed significant effects on growth of D. magna at a concentration of 241 
µg/L during a 21-day assay.  At the same concentration, reproduction was reduced by 32% and 
mortality was increased by 40%.  In the same study, newborns from the 5
th
 brood were exposed 
to the same treatment as their mothers.  Reproduction was reduced significantly at 31 µg/L for 
that second generation – almost a 10-fold lower dose than what inhibited reproduction in their 
mother.  A 30-d chronic toxicity test conducted by Flaherty and Dodson (2005) showed an 
increase in the reproduction of D. magna exposed to 36 g/L of fluoxetine.  The study also found 
that when D. magna were exposed to fluoxetine and clorfibric acid individually, the LC50 was 
580 µg/L and 106 mg/L, respectively (Henry et al., 2004; Henschel et al., 1997).  However, 
when D. magna were exposed to fluoxetine and clorfibric acid in combination, lower amounts of  
fluoxetine  and clofibric acid, 36 g/L and 100 g/L (respectively) resulted in a 62.5% mortality 
rate. 
The aforementioned studies indicate the need for the investigation of environmentally 
relevant mixtures in order to adequately assess environmental risk.  Indeed, while the above 
studies indicate a potential hazard to aquatic organisms, more endpoints and long-term studies 
10 
 
are essential to fully comprehend the ecological risks and impacts of compounds on aquatic 
organisms and their communities (Brooks et al., 2003; Dussault, Balakrishnan, Sverko, Solomon, 
& Sibley, 2008; Sanderson et al., 2004).  Specifically, chronic exposure tests and the potential 
synergistic or antagonistic effects have been under investigated. 
 
Table 2   
 
Summary of EC50, LC50, NOEC and LOEC on Daphnia species for individual pharmaceuticals 
found in the Tennessee River. 
 
Pharmaceutical/      
species Group Endpoint/duration 
Conc. 
(mg/L) (Reference)  
Caffeine Stimulant       
D. magna 
 
reproduction/EC50/17-19-d   
(Olmstead and 
LeBlanc, 2005) 
Sulfamethoxazole Antibiotic 
   D. magna 
 
LC50/24-h 25.2 (Isidori et al., 2005) 
D. magna 
 
LC50/48-h 189.2 (Kim et al., 2007) 
D. magna 
 
LC50/48-h >100.0 (Ferrari et al., 2003) 
D. magna 
 
LC50/96-h 177.3 (Kim et al., 2007) 
Carbamazepine Anticonvulsant 
   D. magna 
 
Immobilization/EC50/48-h >100.0 (Cleuvers, 2003)  
D. magna 
 
LC50/48-h >100.0 (Kim et al., 2007) 
D. magna 
 
LC50/48-h 111.0 (Han et al., 2006) 
D. magna 
 
LC50/48-h >100.0 (Cleuvers, 2003) 
D. magna 
 
LC50/48-h 111.0 
(Sanderson et al., 
2003) 
D. magna 
 
LC50/96-h 76.3 (Kim et al., 2007) 
D. pulex 
 
time to first 
brood/LOEC/21-d 0.2 (Lurling et al., 2006) 
D. pulex 
 
reproduction/NOEC/21-d 0.2 (Lurling et al., 2006) 
Trimethoprim Antibiotic 
   D. magna 
 
LC50/48-h 167.4 (Kim et al., 2007) 
D. magna 
 
LC50/48-h 123.0 
(Halling-Sorensen et 
al., 2000) 
D. magna 
 
LC50/48-h 92.0 
(Park and Choi, 
2008) 
D. magna 
 
LC50/48-h >123.0 
(Stuer-Lauridsen et 
al., 2000) 
D. magna 
 
LC50/96-h 120.7 (Kim et al., 2007) 
D. magna 
 
reproduction/NOEC/21-d 6.0 
(Park and Choi, 
2008) 
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Table 2 cont. 
  Pharmaceutical/      
species Group Endpoint/duration 
Conc. 
(mg/L) (Reference)  
D. magna 
 
reproduction/LOEC/21-d 20.0 
(Park and Choi, 
2008) 
D. magna 
 
time to first 
brood/NOEC/21-d 6.0 
(Park and Choi, 
2008) 
D. magna 
 
time to first 
brood/LOEC/21-d 20.0 
(Park and Choi, 
2008) 
Acetaminophen Analgesic 
   D. magna 
 
LC50/48-h 30.1 (Kim et al., 2007) 
D. magna 
 
LC50/48-h 9.2 (Kuhn et al., 1989) 
D. magna 
 
LC50/48-h 50.0 
(Henschel et al., 
1997) 
D. magna 
 
LC50/48-h 20.0 (Han et al., 2006) 
D. magna 
 
LC50/48-h 42.0 
(Sanderson et al., 
2003) 
D. magna 
 
LC50/96-h 26.6 (Kim et al., 2007) 
Diltiazem 
Calcium 
Channel 
   
 
Blocker 
   D. magna 
 
LC50/48-h 28.0 (Kim et al., 2007) 
D. magna 
 
LC50/96-h 26.6 (Kim et al., 2007) 
Ciprofloxacin Fluoroquinolone  
   
 
Antibiotic 
   
D. magna 
 
NOEC/4- h 10.0 
(Robinson et al., 
2005) 
D. magna 
 
NOEC/48-h 60.0 
(Halling-Sorensen et 
al., 2000) 
Levofloxacin Fluoroquinolone  
   
 
Antibiotic 
   
D. magna 
 
NOEC/48-h 10.0 
(Robinson et al., 
2005) 
D. magna 
 
reproduction/EC50/21-d 0.34 
(Yamashita et al., 
2006) 
D. magna 
 
reproduction/NOEC/21-d 0.31 
(Yamashita et al., 
2006) 
D. magna 
 
reproduction/LOEC/21-d 0.63 
(Yamashita et al., 
2006) 
Sertraline SSRI 
   
D. magna 
 
LC50/24-h 3.1 
(Minagh et al., 
2009) 
D. magna 
 
LC50/48-h 1.3 
(Minagh et al., 
2009) 
C. dubia 
 
LC50/48-h 0.12 (Henry et al., 2004) 
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Table 2 cont. 
  Pharmaceutical/      
species Group Endpoint/duration 
Conc. 
(mg/L) (Reference)  
D. magna 
 
Immobilization/EC50/48-h 0.92 
(Christensen et al., 
2007) 
  
Table 2 cont. 
  C. dubia 
 
reproduction/NOEC/8-d 0.045 (Henry et al., 2004) 
D. magna 
 
reproduction/LOEC/8-d 0.009 (Henry et al., 2004) 
D. magna 
 
LC50/21-d 0.12 
(Minagh et al., 
2009) 
D. magna 
 
Mortality/NOEC/21-d 0.032 
(Minagh et al., 
2009) 
D. magna 
 
Mortality/LOEC/21-d 0.1 
(Minagh et al., 
2009) 
D. magna 
 
reproduction/EC50/21-d 0.066 
(Minagh et al., 
2009) 
D. magna 
 
reproduction/NOEC/21-d 0.032 
(Minagh et al., 
2009) 
D. magna 
 
reproduction/LOEC/21-d 0.1 
(Minagh et al., 
2009) 
Fluoxetine SSRI 
   C. dubia 
 
LC50/48-h 0.58 (Henry et al., 2004) 
D. magna 
 
Immobilization/EC50/48-h 13.0 
(Christensen et al., 
2007) 
C. dubia 
 
reproduction/NOEC/8-d 0.447 (Henry et al., 2004) 
C. dubia 
 
reproduction/LOEC/8-d 1.789 (Henry et al., 2004) 
D. magna 
 
reproduction/LOEC/30-d 0.032 
(Flaherty and 
Dodson, 2005) 
S-fluoxetine 
    D. magna 
 
reproduction/NOEC/21-d 0.195 (Stanley et al., 2007) 
D. magna 
 
reproduction/LOEC/21-d 0.444 (Stanley et al., 2007) 
R-fluoxetine 
    D. magna 
 
reproduction/NOEC/21-d 0.17 (Stanley et al., 2007) 
D. magna   reproduction/LOEC/21-d 0.429 (Stanley et al., 2007) 
1
NOEC, no observed effect concentration. 
2
LOEC, lowest observed effect concentration. 
 
 
Aquatic organisms are routinely exposed to complex mixtures of pharmaceuticals at low 
concentrations (Castiglioni et al., 2006; Kolpin et al., 2002).  However, as indicated above, most 
researchers perform bioassays using single pharmaceutical exposures.  For example, 
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sulfamethoxazole, carbamazepine, trimethoprim, and acetaminophen have been tested 
individually on daphnids (Cleuvers, 2003; Dussault et al., 2008; Grung, Kallqvist, Sakshaug, 
Skurtveit, & Thomas, 2008; Kim et al., 2007). In reality, these compounds occur in combination 
in surface waters (Castiglioni et al., 2006; Conley et al., 2008; Kolpin et al., 2002), and mixtures 
should be analyzed to determine the potential effects of these pharmaceutical mixtures as they 
occur in the environment on aquatic organisms and investigate sub-lethal effects.  Currently, the 
Food and Drug Administration (FDA, 1998) examines a drug for toxic effects at several levels.  
If the compound is found to have properties that suggest it will be degraded at a high rate in the 
environment and does not harm microbes in STPs, then no further examination is undertaken.  
Otherwise, the FDA employs a three tier environmental assessment (EA) to asses the impact of 
the drug.  The first two tiers of the EA measure acute toxicity by performing three assays on 
three types of species, typically a fish, an invertebrate, and an alga.  As long as no sub-lethal 
effects occur, the LC50 for the most sensitive species is divided by the maximum estimated 
environmental concentration.  If this value is greater than or equal to 1000 in the first tier or 100 
in the second tier, no further toxicity assays are performed (FDA, 1998).   It is therefore possible 
for a pharmaceutical to pass FDA guidelines without undergoing a chronic toxicity evaluation, 
which is the last tier in the guideline.  At this time, the US Environmental Protection Agency 
does not have any environmental testing requirements regarding human consumption or 
excretion of pharmaceuticals. 
In this study D. magna was selected for the aquatic toxicology bioassay.  D. magna are 
freshwater zooplankton in inland water ecosystems around the world and play a significant role 
in aquatic food webs (Ternes et al., 2002). Moreover, they are sensitive to foreign chemicals and 
undergo rapid reproduction (Flaherty and Dodson, 2005).  Indeed, they have been showed to be 
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more susceptible to effects from pharmaceutical exposure than other aquatic organisms such as 
the (Oryzias latipes) a Japanese killifish (Kim et al., 2007).   
 
Materials and Methods 
To evaluate the aquatic toxicity of the pharmaceutical mixture detected by Conley et al. 
(2008), a single species 21-d chronic laboratory toxicity test with D. magna was conducted 
(American Society for Testing, 2002).  After the NOEC and LOEC were determined, single 
pharmaceuticals were then tested at the concentration in which they appeared during the mixture 
LOEC toxicity test.  These pharmaceuticals in the LOEC mixture were tested individually in 
order to determine if one of the pharmaceuticals was solely contributing to the results of the 
mixture assay. Sub-lethal endpoints of toxicity were chosen to evaluate effects on the normal life 
cycle of D. magna. Hazard quotients (HQs) were then performed on the NOEC for the mixture 
and single pharmaceutical.  Safety factors were applied to HQs values to account for additional 
stressful interactions that occur in the environment that are not addressed in a laboratory setting. 
A safety factor of 10 was applied (as recommended by the FDA) and a safety factor of 100 was 
also applied as recommended by European standards (EMEA, 2003; FDA, 1998). 
 
D. magna Cultures 
 D. magna individuals were obtained from Aquatic BioSystems, Fort Collins, Co. in 
August of 2009.  An in-laboratory mother culture was created from those individuals and 
maintained in an incubator set at 23
o
C with a 16:8 light to dark cycle.  Mother cultures were 
housed in 1L beakers with approximately 40 adults per beaker.  Culture media was renewed 
twice a week and if neonates were produced they were removed from the mother culture.  All 
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culture water was tested to meet physiochemical requirements set in American Society for 
Testing and Materials (ASTM) 2002 guidelines (e.g., pH and hardness). 
 
Chronic Life Cycle Assay 
 In order to assess the effects of an 11- pharmaceutical mixture to D. magna, life-cycle 
toxicity assays were performed according to ASTM guidelines (ATSM, 2002). When a life cycle 
assay was ready to begin, seven or eight D. magna (less than a week old) were removed from the 
rest of the mother culture and were placed in individual chambers and allowed to reproduce 
(parthenogenically).  Neonates from the 3
rd
 through 7
th
 brood were then used from these D. 
magna to start chronic toxicity assays.  Eleven of those neonates less than 24 hours old were 
randomly transferred to individual test chambers containing 160 ml of test solution.  Five 
endpoints of toxic effect were measured in the present study: (1) length of D. magna at the 
conclusion of the assay, (2) survival of the first generation, (3) total number of neonates 
produced (reproduction), (4) time to the 1
st
 brood, and (5) number of young produced per adult 
female reproduction day. These five endpoints were used to calculate the Lowest Observable 
Effect Concentration (LOEC) and No Observable Effect Concentration (NOEC). 
The test solutions were identical in ratio to the mixture of pharmaceuticals (at maximum 
concentrations) that were detected in the Tennessee River (Table 1) (Conley et al., 2008).  
Nominal test solutions were 10x, 25x, 50x, 75x, 100x and 1000x (the maximum concentration) 
of each pharmaceutical detected in the Tennessee River. These concentrations ranged from a 
single pharmaceutical concentration of .01 µg/L (Diltiazem/Fluoxetine)  to 176 µg/L (Caffeine) 
and a total concentration of 4.96 g/L to 496 g/L, respectively (Table 3).  For example, the 
maximum concentration of caffeine detected by Conley et al. (2008) was 0.176 g/L .  The 10x 
mixture concentration contained 1.76 g/L of caffeine and the 10x maximal values of the other 
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10 pharmaceuticals found in the Tennessee River Conley et al. (2008) resulting in 4.96 µg/L of 
total pharmaceuticals in the 10x test solution (Table 3).  After the 21-d lifecycle LOEC of the 
mixture was determined, 21-d life cycle tests on single pharmaceuticals were conducted.  
 
Table 3  
 
 Maximum concentration of 11 pharmaceuticals detected in the Tennessee River by Conley et al., 
(2008) and the corresponding test concentrations used in the present study.  The 10x mixture 
contained 10 times the maximum concentration of each pharmaceutical detected.  
 Accordingly, the 25x contained 25 times the maximum concentration of each  
pharmaceutical detected, and so forth. 
 
  
Detected 
(µg/L) 
10x 
(µg/L) 
25x 
(µg/L) 
50x 
(µg/L) 
75x 
(µg/L) 
100x 
(µg/L) 
1000x 
(µg/L) 
Caffeine 
0.176 1.760 4.400 8.800 13.200 17.600 176.000 
Sulfamethoxazole 
0.033 0.330 0.825 1.650 2.475 3.300 33.000 
Carbamazepine 
0.023 0.230 0.575 1.150 1.725 2.300 23.000 
Trimethoprim 
0.006 0.060 0.150 0.300 0.450 0.600 6.000 
Acetaminophen 
0.012 0.120 0.300 0.600 0.900 1.200 12.000 
Diltiazem 
0.01 0.100 0.250 0.500 0.750 1.000 10.000 
Ciprofloxacin 
0.054 0.540 1.350 2.700 4.050 5.400 54.000 
Levofloxacin 
0.059 0.590 1.475 2.950 4.425 5.900 59.000 
Atorvastatin 
0.101 1.010 2.525 5.050 7.575 10.100 101.000 
Sertraline 
0.012 0.120 0.300 0.600 0.900 1.200 12.000 
Fluoxetine 
0.010 0.100 0.250 0.500 0.750 1.000 10.000 
Total Concentration 
(µg/L) 
0.496 4.960 12.400 24.800 37.200 49.600 496.000 


Maintenance and Monitoring 
 D. magna (n=11) were individually exposed (each in its own chamber) for 21 days to a 
mixture of pharmaceuticals or single concentrations of pharmaceuticals (Table 3). The control 
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organisms were treated identically (n=11, housed individually), but exposed to only reconstituted 
hard water (RHW).  A solvent control was applied in the same manner only with the exception of 
a solvent added to the medium.  Methanol was used as a solvent for the pharmaceuticals that 
were not water soluble with a maximum concentration of 0.03 µl/L used during the 1000x test.  
Test and control chambers were 80 x 65 (w x h) mm glass wide-mouth jars (Jarden Home 
Brands; Daleville, IN). Each toxicity assay was a static-renewal exposure lasting for 21 days 
wherein the pharmaceuticals were renewed three times a week.  Solutions were prepared the day 
of renewal by serial dilution with RHW, solvent (if necessary), and pharmaceuticals.  Feeding 
consisted of suspensions of green alga (Selenatrum capricornutm) and 50 l TetraMin fish food.  
Depending on the age of the D. magna, the algal ration varied from 4.8 x 10
4
 cells/ml for days 0 
to 3, 5.1 x 10
4
 cells/ml for days 4 to 5, 5.8 x 10
4
 cell/ml for days 6 to 7, 7.7 x 10
4
 cell/ml, for 
days 8 to 9, and 9.6 x 10
4
 cell/ml for days 10 to 21 (Phillips, Dinglasan-Panlilio, Mabury, 
Solomon, & Sibley, 2010).   Reproduction (number of neonates) was monitored every day but 
neonates were only removed when solution was renewed.  Neonates were removed via a large-
mouth pipet and concentrated on filter paper where they could be accurately counted.  After the 
conclusion of the experiment adult body size was measured from top of the head to base of tail 
Lopes et al. (2009), using a Peak glass scale under an Olympic CX-31 compound microscope.  
D. magna were measured to the nearest mm.  Mortality was monitored each day until the 
conclusion of the experiment.   
 
Hazard Assessment 
 Environmental hazard posed by the mixture and single pharmaceuticals found in the 
Tennessee River was assessed by the calculation of hazard quotients (HQs).  HQs are designed to 
show the potential effects that the mixture and single pharmaceuticals potentially have on the 
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aquatic environment (FDA, 1998, EPA, 2008).  The HQ was mathematically calculated by using 
the following equation:  
                                                         HQ =                           2.1 
Where MEC represents the maximum environmental concentration in the Tennessee River and 
NOEC represents the no observed effect concentration for the most sensitive endpoint.  The 
MEC found in the Tennessee River was used for single pharmaceuticals and mixture HQ 
determination along with the highest NOEC to ensure a conservative estimate of hazard.   An 
HQ value <1 indicates toxicity is not likely to occur where as an HQ value >1 indicates an 
apparent hazard to D. magna (Han, Hur, & Kim, 2006).  Safety factors of 10 and 100 were 
applied to the HQ values to account for interspecies variability and interaction that may cause 
stress on organisms in the environment that are not assessed in a laboratory setting (Robinson, 
Belden, & Lydy, 2005).  
 
Statistics 
 Effects of various pharmaceuticals concentrations on different endpoints were compared 
using one-way repeated-measures analysis of variance (ANOVA) followed by a post-hoc Tukey 
test (α = 0.05). Normality of data was checked using a Shapiro-Wilk test.  Reproduction data 
(raw values) were normalized by converting to percent of control.  This allowed for direct 
comparisons between life cycle assays that were performed at different times.  All statistical 
analyses were conducted using Statistical Analysis System (SAS Inc., 2008).    
 
 
 
 
MEC 
NOEC 
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Results 
 
 Pharmaceutical Mixture Chronic Assay   
 Of the five endpoints evaluated (length, survival of the first generation, reproduction, 
time to the first brood, and number of young produced per adult female reproduction day), only 
reproduction was significantly affected in the mixture life cycle assay.  Criteria for acceptable D. 
magna control survival (>70%) and reproduction (>60 neonates per female) were met during all 
assays (ASTM, 2002).  The number of young produced per female reproduction day stayed 
moderately similar at nine to ten for control and lower concentrations.  At the 100x 
concentration, number of young produced per female reproduction day dropped slightly to 8.6 
neonates (88% of control, p > 0.05).  In the 1000x concentration, number of young produced per 
female reproduction day dropped significantly to 2.1 (28% of control, p <0.0001 ) neonates per 
female reproduction day (Fig. 1).  Fecundity was significantly reduced at 100x (49.6 μg/L total 
concentration; p= 0.005) and 1000x (496.0 μg/L total concentration; p >0.0001).  No observed 
effects were seen in mixture treatments that were 75x and lower, resulting in a NOEC of 75x 
(37.2 μg/L total concentration of pharmaceuticals) (Fig. 2).     
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Figure 1 
 
Mean numbers of young produced per female reproduction day are express as the percent of the 
control value.  An asterisk indicates that the mean response was significantly different from that 
of the control (p < 0.05).  Error bars represent standard errors. 
 
 
 
 
Figure 2 
 
Effects of pharmaceutical mixtures on the reproduction of D. magna. Mean numbers of D. 
magna neonates produced are expressed as the percent of the control during a 21-day life cycle 
assay.  An asterisk indicates that the mean response was significantly different from that of the 
control (p < 0.05).  Error bars represent standard errors. 
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Individual Chronic Assay 
When the LOEC (100x) was observed for the mixture of pharmaceuticals, life cycle test 
were preformed on individual pharmaceuticals to determine if one or more pharmaceutical might 
be driving the decrease in reproduction.  Assays were performed using the individual 
pharmaceutical concentrations that were present in the LOEC for the mixture assays.  All single 
pharmaceuticals were statistically similar to their control for all endpoints (p > 0.05).  However, 
ciprofloxacin and levofloxacin showed a non-significant decrease in reproduction with 87.57% 
and 88.27% of control, respectively.  Caffeine, sulfamethoxazole, carbamazepine, trimethoprim, 
sertraline and fluoxetine showed a slight increase in reproduction when compared to control 
treatments (Fig. 3) 
 
Figure 3 
 
Single pharmaceutical assays results for D. magna reproduction.  Numbers of D. magna neonates 
produced are expressed as percent of control values during a 21-day life cycle assay. No 
statistical significance was observed for any of the single pharmaceuticals at their concentration 
in the LOEC for the mixture.  Error bars represent standard error. 
0 
20 
40 
60 
80 
100 
120 
140 
N
u
m
b
er
 o
f 
N
eo
n
a
te
s 
 (
p
er
ce
n
t 
o
f 
C
o
n
tr
o
l)
 
Individual Pharmaceutical conc. present in LOEC (for mixture assays) 
22 
 
Hazard Assessment 
Hazard quotients (HQs) were calculated in order to estimate the hazard that individual 
pharmaceuticals and a mixture of pharmaceuticals may pose for daphnids in the Tennessee 
River.    When all pharmaceuticals were considered as a mixture, the HQ, with a safety factor of 
100, was >1 (Table 4).  Moreover, the individual pharmaceuticals caffeine, sulfamethoxazole, 
and diltiazem also had HQ values > 1 when a safety factor of 100 was applied to the 
pharmaceutical maximum environmental concentration found in the Tennessee River (TN. 
MEC) (Table 4).  This is due to the conservative NOEC numbers for the single pharmaceuticals 
used in the HQ calculation.  The actual NOEC for single pharmaceuticals may be orders of 
magnitude higher then what was estimated in the current study.   Four of the 11 pharmaceuticals 
in the present study have been studied previously for effects on D. magna 21-day reproduction.  
In those studies, carbamazepine, trimethoprim, levofloxacin, and sertraline produced NOEC at 
200 µg/L, 6,000 µg/L, 310 µg/L, and 32 µg/L, respectively (Lurling et al., 2006, Minagh et al., 
2009, Park and Choi, 2008, Yamahita et al., 2006).  Those values are orders of magnitude higher 
than the present study estimates of NOEC.  When these NOEC values for the four 
pharmaceuticals were used to calculate HQ, a more realistic value was produced.  In this study 
the HQs for all four pharmaceuticals was < 1 even after a safety factor of a 100 was applied 
(Table 2).  When MECs from around the world were combined with the NOEC values observed 
herein, an HQ >1 was produced (1.9) – without the addition of a safety factor (Table 4).   
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Table 4 
 
Hazard quotients (HQs) for D. magna when calculated using the highest Tennessee River 
measured environmental concentration (TN. MEC) with the no observed effect concentration 
observed for reproduction in the present 21-day study (TN. NOEC). Values >1 indicate an 
apparent hazard to D. magna.  Literature MEC (Lit. MEC) are maximum concentrations  
detected globally.  The Lit. NOEC is the NOEC value taken from the  
literature (except for the Mixture value). 
 
Pharmaceutical 
TN. MEC/ 
TN. NOEC 
Safety factor 
of 10 
Safety   factor 
of 100 
TN.MEC/Lit. 
NOEC 
Lit. MEC/ Lit. 
NOEC 
Caffeine 0.0100 0.1002 1.0017 
 
0.3415
e
 
Sulfamethoxazole 0.0100 0.1000 1.0000 
 
1.5758
f
 
Carbamazepine 0.0100 0.0996 0.9957 0.0001
a
 1.0823
g
 
Trimethoprim 0.0095 0.0952 0.9524 1x10
-6 b
 1.1270
e
 
Acetaminophen 0.0098 0.0976 0.9756 
 
8.1301
e
 
Diltiazem 0.0103 0.1031 1.0309 
 
0.0103
k
 
Ciprofloxacin 0.0100 0.0996 0.9963 
 
0.0066
e
 
Levofloxacin 0.0099 0.0995 0.9949 0.0002
c
 0.0017
i
 
Atorvastatin 0.0100 0.0997 0.9970 
 
0.059
j 
Sertraline 0.0097 0.0968 0.9677 0.0004
d
 0.4597
h
 
Fluoxetine 0.0099 0.0990 0.9901   0.0337
g
 
Mixture 0.0133 0.1329 1.3294 
 
1.9171
l
 
a 
NOEC Lurling et al. (2006) 
b 
NOEC Park and Choi (2008) 
c 
NOEC Yamashita et al. (2006) 
d 
NOEC Minagh et al. (2009) 
e 
MEC Kolpin et al. (2002) 
f  
MEC Cahill et al. (2004) 
g
 MEC Sadezky et al. (2010) 
h
 MEC Thomas and Hilton (2004) 
i 
MEC Metcalfe et al. (2003) 
j
 MEC Lee et al. (2009) 
k
 MEC Conley et al. (2008) 
l
 MEC present study 
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Discussion  
 
Pharmaceutical Mixture Toxicity 
 When assessing hazard of a compound, the more conservative estimate is safest for the 
environment.  Therefore, the present experiment and HQ calculations were designed to represent 
the worst-case scenario of the pharmaceutical mixture found in the Tennessee River.  All 
pharmaceuticals tested in the present mixture were not detected in every surface water sample, 
nor was every sample detected at the maximum concentration (Conley et al., 2008).  The results 
from the present study indicate that the mixture of pharmaceuticals has a lower LOEC than any 
of the individual pharmaceuticals separately, when considering reproduction as the endpoint 
(Fig.2).  This is likely due to the fact that the total amount of xenobiotic the D. magna were 
exposed to in the mixture study was 49.6 µg/L (in the LOEC) (Fig. 2) versus the single 
pharmaceutical study which ranged from 0.6 µg/L to 17.6 µg/L.  This indicates that there is some 
type of additive effect.  It is not known if there is some antagonistic effect occurring.  For 
example, 10 of the pharmaceuticals could work in an additive manner, while one works in an 
antagonistic manner, thus reducing the total additive effect of the 10 pharmaceuticals.  Thus, it is 
possible that fewer pharmaceuticals may have a greater effect (not likely), but this could not be 
determined in the present study. The fact that reproduction was the only endpoint significantly 
reduced is not unexpected because reproduction has been shown to be one of the most sensitive 
endpoints in D. magna (Minagh et al., 2009).  In the 100x concentration, reproduction was 
reduced to 85% of control.  The 1000x concentration caused reproduction to be reduced to 35% 
of control indicating reproduction was affected in a dose dependent manner by the mixture.  This 
drop in the total number of neonates is proportional to the number of young per adult female 
reproduction days observed in 100x and 1000x concentrations (Fig.2).  The results here support 
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previous studies reported by Park and Choi (2008) that have shown that reproduction is dose 
dependent.  These workers found a dose dependent response on population effects when 
investigating the aquatic toxicities of eleven antibiotics on D. magna.  Accordingly, Cleuvers 
(2008) conducted a study investigating the chronic effects of naproxen, ibuprofen, and diclofenac 
mixture on D. magna and found that reproduction was also reduced in a dose dependent manner 
by the mixture.  That study also showed that the highest concentrations of 22.62 mg/L, 22.97 
mg/L, and 64.18 mg/L of diclofenac, ibuprofen, and naproxen, respectively, reduced 
reproduction by 100%.  This is noteworthy due to the fact that mortality was not observed at this 
concentration.  Data such as these reaffirm the need to use sub-lethal parameters as endpoints to 
address the pharmaceuticals' potential environmental risk.   
The HQ for the pharmaceutical mixture of this study (calculated using Tennessee River 
MECs) was 0.013.  When a safety factor of 10 was applied the mixture HQ was still below 1. 
This indicates that the mixture of pharmaceuticals currently detected in the Tennessee River 
poses an insignificant hazard for D. magna at concentrations 10x greater than what is currently 
maximally detected – according to FDA guidelines (FDA, 1998).  Furthermore, a safety factor of 
100 had to be applied before the HQ value exceeded 1.  European Union (EU) surface water 
hazard assessments commonly apply a safety factor of 100 to HQs (EMEA, 2003).  Thus, the 
mixture of pharmaceuticals currently detected in the Tennessee River poses an apparent hazard 
for D. magna at 100x if EU standards are applied.  The fundamental purpose of the addition of 
safety factors is to account for stressors in the environment that cannot be duplicated or 
accounted for in the laboratory – especially in lower-tier hazard assessments such as the present 
study (Solomon et al., 2008). While safety factors (also referred to as uncertainty factors) are 
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somewhat arbitrary in their numerical value, they have utility in presenting a conservative 
estimate.    
Because pharmaceutical use occurs worldwide, it is appropriate to use MECs found 
outside of the Tennessee River.  If the worldwide MEC (where measurements have been taken) is 
applied to the NOEC found in the current study for the mixture, the HQ would be greater than 1 
with no safety factor applied (Table 4).   Thus, in surface waters that approach the worldwide 
MEC for all pharmaceutical in the present mixture, there is a hazard to D. magna.   This is a very 
conservative assessment.  However, this HQ does not account for any of the uncertainties 
associated with laboratory to field extrapolation.  Nor does this HQ consider the increasing 
human population, the increasing age of the human population, increasing pharmaceutical use, 
and additive effects of potentially hundreds of pharmaceuticals. Therefore, while the scenario of 
combined MECs co-occurring is unlikely, one still needs to consider all of the present and future 
variables before discounting the hazard illustrated in the present mixture HQ calculations. 
 
Individual Pharmaceutical Toxicity 
The main purpose of conducting the studies on the singular pharmaceuticals was to 
determine if one or more of the single pharmaceuticals were solely responsible for reduced 
reproduction.   No single pharmaceutical was the driving factor (Fig. 3) (i.e., no singular 
pharmaceutical was as toxic as the mixture) (Table 4).  All HQs values were <1 for MECs - even 
when a safety factor of 10 was applied.  It should be noted that further tests to define a more 
accurate NOEC or LOEC were not performed, as this was beyond the scope of the present study.  
As such, the NOECs for single pharmaceuticals could be much lower than what is reported in the 
present study.  This would result in HQs to be much lower than what is presented herein for the 
individual pharmaceutical hazard potential.    
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 Two single pharmaceutical tests did show a drop (statistically insignificant) in 
reproduction for ciprofloxacin and levofloxacin of 87.5% and 88.2%, respectively (p> 0.05) (Fig. 
3).  Both of these compounds are antibiotics and belong to the fluoroquinolone class.  
Fluoroquinolones, have a fluorine atom added to their structure to enhance the antibiotic action 
against gram negative and positive bacteria (Robinson et al., 2005).  This class of antibiotics is 
commonly used and because it is an antibiotic, it is not readily biodegradable (Al-Ahmad, 
Daschner, & Kummerer, 1999).  Most antibiotics are developed to have a specific metabolic 
pathway in humans and/or domestic animals but when exposed to non-target organisms, they 
often have various and unknown effects (Daughton & Ternes, 1999).    
Neither levofloxacin or ciprofloxacin was found to pose a significant risk when tested in 
an acute 48-hour survival test of D. magna with a NOEC at 10 mg/L (Robinson et al., 2005).  
However that study's sole endpoint was survival and only lasted two days. In the present study, 
exposure concentrations for levofloxacin and ciprofloxacin were 5.9 µg/L and 5.4 µg/L, 
respectively, and exposure lasted for 21 days.  Halling-Sorensen et al. (2000) reported a NOEC 
of 60 mg/L when D. magna were exposed to ciprofloxacin during a 48-h assay.  Data for 
pharmaceutical life cycle toxicity assays are sparse.  Levofloxacin was one of four 
pharmaceuticals in the current study for which NOEC and LOEC values for a single 
pharmaceutical 21-d reproduction were available.  Yamashita et al. (2006) found reproduction 
NOEC and LOEC for levofloxacin in D. magna to be 310 µg/L and 630 µg/L, respectively 
(Table 2). In the present study, the concentration of levofloxacin was 5.9 µg/L in the mixture 
LOEC.  In the present study, both ciprofloxacin and levofloxacin were found to have NOEC at 
5.4 µg/L and 5.9 µg/L, respectively.  Future studies should try to find the NOEC and LOEC for 
ciprofloxacin in order to better assess this fluoroquinolone chronic exposures hazard.   
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The antibiotic trimethoprim was found to have a LOEC of 20 mg/L and a NOEC of 6 
mg/L in a 21-day assay with D. magna (Park & Choi, 2008).  These results tend to suggest that 
trimethoprim is not one of the driving compounds involved in decreased reproduction found in 
the mixture because the LOEC observed associated with a significant decrease in reproduction is 
1000x greater than what was tested in the current study.   The longest assay that could be found 
in the literature for sulfamethoxazole lasted 96 h which calculated an LC50 of 177.3 mg/L (Kim 
et al., 2007).   Sulfamethoxazole was found to have a NOEC of 3.3 µg/L. Since no attempt was 
made to pinpoint the LOEC for sulfamethoxazole this NOEC is a conservative estimate.  
The antiepileptic drug, carbamazepine, has been shown to significantly stimulate D. pulex 
reproduction when exposed to 1 µg/L.  This concentration produced more neonates than the 
controls or any other higher treatment (Lurling, Sargant, & Roessink, 2006).  However, at higher 
concentrations of 100 and 200 µg/L, the rate of population growth was 9% and 32%, respectively 
(not statistically significant).   Results from Lurling et al. (2006) suggest that carbamazepine has 
stimulatory effects at the environmental relative concentration and a NOEC at 200 µg/L.  In the 
current experiment, the NOEC for carbamazepine was 2.3µg/L; although, there was an 
insignificant increase in reproduction that resulted in 107 percent of control (p=0.11) (Table 2).  
A significant increase in reproduction would indicate that carbamazepine was acting as an 
antagonist in the mixture LOEC.  Cleuvers (2003) found that carbamazepine, when combined 
with clofibric acid, followed the concept of addition and as a result had a much stronger effect 
than when tested individually.  Admittedly, our results, as well as those of Lurling et al. (2006) 
and Cleuvers (2003), are not enough to make definite statements regarding mixture toxicity, but 
it does illustrate how some pharmaceuticals in the mixture could be working against the 
reproductive inhibitory effects of the rest of the mixture.   
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Fluoxetine and sertraline are in a class of pharmaceuticals known as selective serotonin 
reuptake inhibitors (SSRIs).  These drugs are developed to inhibit the reuptake of serotonin in the 
postsynaptic cleft of mammals but in non-target organisms, serotonin may be responsible for 
mechanisms that may alter appetite or influence behavior and sexual function (Fent et al., 2006; 
Richards & Cole, 2006; Schloss & Williams, 1998).  As mentioned previously, fluoxetine has 
been shown to have stimulatory effects on reproduction when acting alone but also decreased 
reproduction in mixtures (Flaherty & Dodson, 2005).  Richards et al. (2004) exposed aquatic 
microcosms to ibuprofen, fluoxetine and ciprofloxacin at concentrations of 60 µg/L, 100 µg/L, 
and 100 µg/L, respectively, and found that zooplankton abundance increased but diversity 
decreased directly in proportion to the dose. The other SSRI tested in that mixture, sertraline, has 
been shown to have a LOEC at 100 µg/L in a 21-day assay as well as a NOEC on reproduction at 
32 µg/L when D. magna were exposed (Minagh et al., 2009).  This is the lowest observed LOEC 
found for any of the individual pharmaceuticals in a 21-d life cycle assay on D. magna.  A study 
conducted by Henry et al. (2004) investigated the 8-d chronic toxicity of five SSRI on 
Ceriodaphnia dubia, a water flea similar to D. magna.  The LOECs for fluoxetine and sertraline 
were 146 µg/L and 45 µg/L, respectively. The fact that SSRIs used in this study have been found 
to reduce reproduction in D. magna at µg/L levels could suggest that they may have had a role in 
the reduced number of neonates in the current mixture study. 
 
Data Gaps and Uncertainties 
Out of the 11 pharmaceuticals that made up the mixture in the current study only four 
could be found in the literature with NOEC values for 21-day assays that evaluated reproduction 
of D. magna as an endpoint (Table 1). Trimethoprim’s NOEC was the highest reported at a 
concentration of 6 mg/L (Park & Choi, 2008).  Sertraline had the lowest NOEC at 32 µg/L 
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(Minagh et al., 2009).  The lack of data available for these individual pharmaceuticals need to be 
addressed in order to know their potential hazard in chronic exposure scenarios.  When the 
LOEC was observed for the mixture at 100x, 21-d assays were conducted on the individual 
pharmaceuticals in order to determine if one was responsible for the reduction in neonates 
produced.  As a result NOECs were found for each pharmaceutical at their concentration within 
the mixture LOEC.  No attempt was made to find the LOEC for any of the individual 
pharmaceuticals as this was outside the scope of the current study.  As a result, our NOEC for the 
single pharmaceuticals may be orders of magnitude lower than the actual NOEC.  As mentioned 
earlier, HQs for the individual pharmaceuticals calculated herein must be seen as highly 
conservative estimates.  For example, the NOEC found for trimethoprim in the current study was 
0.6µg/L whereas the NOEC reported in the literature is 6 mg/L (Park & Choi, 2008).  Our NOEC 
is > 1,000x lower than what is reported in the literature causing our HQ for trimethoprim to be 
highly conservative.   The NOEC in the present study illustrates how little hazard trimethoprim 
poses.  Indeed, even though an extremely conservative NOEC estimate was used to calculate the 
HQ, no hazard is predicted for trimethoprim – with a safety factor of 100 applied.  In the least, 
the estimated trimethoprim HQ of this study provides only a relative estimate of hazard.    
A similar situation exists for sertraline.  Sertraline’s literature NOEC is 32 µg/L (Minagh 
et al., 2009).  The present study estimated a NOEC of 1.24 µg/L.  This is also a conservative 
estimate (25x lower than the reported NOEC) and no hazard is predicted for sertraline, even with 
a safety factor of 100 applied.  Seven of the pharmaceuticals do not have data in the literature for 
21-day reproduction assays; therefore, similar comparisons of literature NOEC and present-study 
NOEC cannot be made. 
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Conclusions 
 The occurrence of pharmaceuticals as complex mixtures and at low concentrations is well 
documented around the globe.  Most studies that address the acute ecological hazard of 
pharmaceuticals only account for the toxicity of single pharmaceutical exposure and do not take 
into account chronic additive or synergistic affects that can occur in mixtures.  This is concerning 
given the fact that low-level combinations of pharmaceuticals are continually released into the 
aquatic environment with aquatic species being exposed over the course of their life cycles.   
Herein, we attempted to determine the hazard of environmentally relevant mixtures of 
pharmaceuticals to D. magna.  My results indicate that the LOEC for such a mixture was below 
the NOEC for any single pharmaceutical, indicating that interactions or cumulative effect of the 
mixture resulted in greater toxicity.  When these data were used to calculate a conservative HQ, 
no hazard was indicated.  When a safety factor of 10 was applied to the HQ, as recommended by 
the FDA, the predicted hazard for D. magna exposed to the pharmaceutical mixture – at 
maximum environmental concentrations – is low.   
My experimental data suggest that current hazard of the 11 pharmaceutical mixture in the 
environment is low.   However, some consideration needs to be given to future hazard due to the 
increasing size and age of human populations and associated subsequent increases in 
pharmaceutical use.  In addition, the present research (and that of others) indicates that as the 
number of pharmaceuticals is added to the system, toxicity is likely increase as well.  Conley et 
al. (2008) measured for 14 pharmaceuticals in the Tennessee River and found 13.  Which raises 
the questions:  what if they measured for 140 pharmaceuticals?  Would Conley et al. (2008) have 
found 130 pharmaceuticals?  With over 3000 active ingredients in use today, the possibility of 
many more pharmaceuticals in the environment cannot be ignored.  The use of safety factors will 
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compensate for much of this uncertainty, but it is difficult to determine how much.  Indeed, the 
present study has illustrated how toxicity increases (relative to individual concentrations) when 
ultra-low concentrations are combined.  In the present study we have shown that if D. magna are 
exposed to 11 pharmaceuticals simultaneously at the maximum environmental concentration that 
were detected in the Tennessee River, the threshold for significant reproductive hazard would not 
be reached unless concentrations increased by a factor of 100.  While this is indeed orders of 
magnitude away from a perceived hazard, it is difficult to determine how long, or if, this 100-
fold safety could be diminished as human populations grow. 
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CHAPTER III 
 
DETERMINATION OF RIVERINE ZOOPLANKTON ASSEMBLAGE 
RELATION TO CHITOBIASE ACTIVITY 
 
Introduction 
       Invertebrate diversity and biomass are standard indicators of stream health (Reynoldson 
& Metcalfe-Smith, 1992). The diversity of invertebrate taxa found in lotic systems can be 
incredibly complex.  In the southern Appalachian Mountains, over 293 invertebrate taxa have 
been recorded in headwater streams (Wallace & Eggert, 2009).  Zooplankton are a vital part of 
the aquatic ecosystem.  In a riverine food web, zooplankton provide a vital link between 
phytoplankton and fish (Jack & Thorp, 2002; Thorp & Delong, 2002). Zooplankton are a 
significant biotic component of the carbon cycle in larger riverine ecosystems (Gliwicz, 2002; 
Gosselain et al., 1998; Thorp & Delong, 2002).   
 Methods that are currently used by researchers to measure aquatic invertebrate diversity 
are expensive, due to the amount of time and labor it takes to collect and process invertebrate 
samples (Bailey et al., 2001; Lenat & Resh, 2001).  There is a need for alternative methods that 
have the potential of assessing aquatic invertebrate populations rapidly and at low cost. One such 
method that has shown promise for invertebrate assessment is the monitoring of chitobiase 
activity in the water column (Hanson & Lagadic, 2005; Sastri & Dower, 2009).   Chitobiase 
along with chitinase are two chitinolytic enzymes that partially digest the chitin exoskeleton of 
crustaceans in a process called apolysis.  Chitin consists of a polymer of -(1-4)-linked sugar 
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derivatives.  The chitinolytic enzymes break down chitin with chitinase, cleaving the chitin to 
oligomers and dimers.  Chitobiase then degrades the products to the monomer N-
acetylglucosamine (NAG) (Espie & Roff, 1995; Oosterhuis et al., 2000).  Both enzymes are 
released into the ambient water during the pre-molt stage of arthropods (Zou & Fingerman, 
1999).  Since chitinase and chitobiase are essential for molting to take place and are released in 
the water column, ambient concentrations of these enzymes have the potential to represent total 
molting activity or biomass production of arthropod populations (Conley et al., 2009; Sastri & 
Dower, 2009). Chitobiase is a good choice as a natural tracer, due to the established and simple 
assay used to calculate its presence in the water column (Espie & Roff, 1995).   
 Vrba and Machacek (1994) observed that chitobiase is liberated into the surrounding 
aquatic environment after apolysis.  Oosterhuis et al. (2000) measured the rate of chitobiase 
released by T. longicornis and found that chitobiase activity provided a good natural indicator for 
body weight increase.  Most recently, Sastri and Dower (2009) found a significant positive 
relationship between total zooplankton biomass and liberated chitobiase (r
2
=0.41) off the coast of 
British Columbia.  These studies showed the potential of monitoring chitobiase activity and 
indirectly measure the total invertebrate biomass of an aquatic system in an extremely short 
amount of time (Hanson & Lagadic, 2005).   
 To date, no research has examined the relationship between chitobiase activity and 
zooplankton assemblages in freshwater river systems.  To achieve this, zooplankton and 
associated water samples were collected over the course of 2010-2011 from 4
th
-6
th
 order 
Tennessee River tributaries, with one sampling period during each season. This allowed for a 
snapshot of zooplankton assemblages and the concentration of chitobiase activity in lotic 
ecosystems (Dodson et al., 2009). By measuring zooplankton and chitobiase parameters at the 
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same point and time, I aimed to determine the relationship between zooplankton and ambient 
chitobiase activity concentration.    
 
Materials and Methods 
 
Study Sites 
 Study creeks include Wolftever Creek (N 35˚ 08’02.62’’, W 85˚ 04’39.88’’ ), Soddy 
Creek (N 35˚ 17’47.24’’, W 85˚ 08’57.03’’), North Chickamauga Creek (N 35˚ 06’49.78’’, W 85˚ 
13’45.38’’) and South Chickamauga Creek (N 35˚ 05’17.87’’, W 85˚ 15’43.73’’) were sampled 
during four seasons.  These creeks were sampled once per season in the Spring (5/25/2010), 
Summer (8/25/2010), Fall (10/27/2010), and Winter (2/11/2011).  Sequatchie River (N 35˚ 
02’52.97’’, W 85˚ 37’34.07’’), and Candies Creek (N 35˚ 18’36.75’’, W 84˚ 50’50.06’’) were 
added later and samples were only taken during the Summer, Fall, and Winter.  All creeks are 
located in the Tennessee River watershed and are classified as 4
th
 order or higher. 
 
Sampling 
 Zooplankton sampling was carried out using the procedure from Havel et al. (2009).  This 
method provided an accurate volume measurement between sample sites and collected via a 
Guzzler hand-pump (Model 400h) and then filtered through plankton nets.  In order to accurately 
estimate the density of all major groups of zooplankton, two plankton net sizes were used.   
Macrozooplankton were collected by pumping a total of 180 L of water through a 63 m mesh 
plankton net.  This allowed for a proper estimation of crustacean zooplankton (Chick, Levchuk, 
Madley, & Havel, 2010).  This large amount of water that was pumped through the net allowed 
for a better estimate of macrozooplankton that are most scarce.  Microzooplankton were 
collected by pumping a total of 18 L through a 20 m mesh plankton net (Angradi, 2006; Havel 
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et al., 2009).  Micro samples were used to estimate rotifers and copepod nauplii that would not 
be captured in the larger net size.  By using this dual net system the most accurate estimates were 
obtained for all of the aforementioned zooplankton taxa (Chick et al., 2010).  Depth of samples 
ranged according to the size of the creek channel (Fig. 4).  Viroux (1999) conducted a study that 
indicated zooplankton density is not evenly distributed in the water column of lotic systems. To 
insure accurate measurement of the river zooplankton assemblage, samples were collected from 
three vertical points and three horizontal points when possible.  Vertical samples were collected 
0.5 m below the surface, at the mid-channel depth, and at 0.5 m above channel bed (a, b, and c, 
respectively; Fig. 4) (Angradi, 2006).  Horizontal samples were collected at the center of the 
channel and at half the distance from the shore on either side of the center (Fig. 4).   A 20 L 
sample of water was collected from each point for macrozooplankton and 2 L for 
microzooplankton;  samples were then combined for a total volume of 180 L and 18 L.  All 
samples were preserved in 95% ethanol for processing (Angradi, 2006; Havel et al., 2009). At 
the time of zooplankton sampling, a water sample was collected from the vertical mid-channel 
depths to determine ambient chitobiase activity within the water column. 
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Figure 4 
 
Simulated cross section of a river channel. Letters indicate zooplankton sampling points. 
Samples were collected at (a) 0.5 m below surface, (b) mid depth and (c) 0.5 m above river bed. 
Horizontal samples were collected at the center of the channel and at half the distance from the 
shore on either side of the center A 20 L sample was collected from each point for 
macrozooplankton and 2 L form each point for microzooplankton. 
 
Zooplankton analysis 
 Zooplankton samples were processed by BSA Environmental Services Cleveland, OH.  
Briefly, concentrated samples were measured in three 1 ml aliquots under a Wilovert inverted 
microscope outfitted with a phase contrast until 400 specimens were counted.  Density was then 
expressed in number of individuals per liter (ind./L) based on the volume of water pumped 
through the net (Beaver et al., 2010; Havens et al., 2011).  Taxonomic identification followed 
methods from Ruttner-Kolisko (1974),  Stemberger (1979), and Edmundson (1959).  Biomass 
estimates were based on established length-width relationships (Lawrence, Malley, Findlay, 
Maclver, & Delbaere, 1987; McCauley, 1984).  Biomass was estimated for each location and 
season with a species biomass calculated for each sample. 
 
Chitobiase Activity Analysis 
The method to fluorometrically measure chitobiase activity is well established and has 
been used in previous studies by Hanson and Lagadic (2005) and Conley et al. (2009). This assay 
a a a 
c 
c 
b 
c 
b 
b 
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indirectly measures chitobiase activity by quantifying liberated methylumbelliferyl acetate 
(MUF) from a 4-Methylumbelliferyl-2-acetamido-2-acetamido-2-deoxy-β-D-glucopyranoside 
(MUF-NAG) substrate.  When samples are introduced to the MUF-NAG substrate, chitobiase 
within the water sample cleaves the substrate into MUF and NAG.  The fluorescent MUF is then 
quantified with a spectrophotometer set at 360 nm excitation and 450 nm emission (Hanson & 
Lagadic, 2005).  Samples first were filtered using a 0.7 m glass fiber filter and then through a 
0.45 m membrane filter. This process removed free-floating particulates in the sample.  
Samples were next filtered with 0.2 m filter to remove any bacteria that may interfere with the 
test.  Samples were stored in a -80
o
 C freezer until analysis.  On the day of quantitation, samples 
were thawed and then incubated with 50 l of 0.31 mmol
.
L
-1
MUF-NAG in 0.15 mol
.
L
-1 
5.5 
citrate phosphate buffer for 1 hour at 25
o
C.  After an hour, 50 l of 0.25 M NaOH was added to 
stop the reaction. The ambient chitobiase activity was analyzed using a BIO-TEK synergy HT 
spectrophotometer and was expressed as fluorescence of freed MUF in micromoles per liter per 
hr (µmol·L
-1
·h
-1
) at 360 nm excitation and 450 nm emission.  To measure the fluorescence 
absorbance, a standard curve was produced using stock solutions of MUF (Conley et al., 2009, 
Hanson and Lagadic, 2005). 
 
Statistics 
All statistics where preformed with Statistical Analysis System (SAS Inc., 2008). Two 
factor repeated-measures ANOVA without replication on ranks was used to determine 
significance between seasons for chitobiase activity and biotic factors (α = 0.1).  These biotic 
factors included biomass value for total zooplankton, macro zooplankton, micro zooplankton, 
cladocerans, copepods, nauplii, macro sample combined with nauplii, and copepods with nauplii 
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biomass. Zooplankton abundance was analyzed for the above mentioned groups as well. Data did 
not meet normality assumptions so ranked values were used in all ANOVAs.  To evaluate 
possible differences between means, pairwise comparisons were performed using Tukey’s test.  
To compare the effect of season, separate tests were run on four creeks over four seasons 
(Wolftever Creek, Soddy Creek, North Chickamauga Creek and South Chickamauga Creek) and 
six creeks over three seasons (Wolftever Creek, Soddy Creek, North Chickamauga Creek, South 
Chickamauga Creek Sequatchie River and Candies Creek).  Data that underwent ANOVA tests 
were chitobiase activity taken during each season along with the aforementioned groups of biotic 
factors.   
 
Results 
 Seasonal analysis on chitobiase activity showed no significant difference for chitobiase 
activity among the four creeks over four seasons (Two factor repeated measure ANOVA without 
replication on ranks; p > 0.1) (Table 5).  Although there was no significant difference, Fall had 
the highest mean chitobiase activity followed by Summer, Spring, and then Winter. There was no 
significant difference in biomass between seasons for the four creeks over four seasons (p > 0.1)  
(Table 6).  However, abundance did show significant differences (Table 5).  For total abundance, 
pairwise comparison indicate Summer zooplankton abundance was significantly greater than 
Winter abundance ( p = 0.062), but Fall and Spring samples were similar to both Summer and 
Winter.  Samples of Copepoda combined with napulii, macro combined with napulii, and napulii 
individuals were found to be significantly different for Summer and Fall when compared to 
Winter.  Fall samples were found to be similar to all seasons (Table 5).  
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Table 5 
 
Chitobiase activity and zooplankton abundance mean ranks in regard to season for four creeks 
over four seasons.  Letters indicate a significant difference in Tukey’s test groupings (α = 0.1).  
All significant difference in groupings follow the pattern of Summer having the largest mean 
followed by Spring, Fall, Winter for biotic factors. 
 
Parameters Spring Summer  Fall Winter 
Chitobiase 6.75 10.00 10.50 6.75 
Total 9.50
a,b
 12.75
a
 7.75
a,b
 4.00
b
 
Macro 9.25 11.00 8.87 4.88 
Micro 9.50
a,b
 12.75
a
 7.75
a,b
 4.00
b
 
Cladocera 9.12 11.25 8.37 5.20 
Copepoda 9.12 10.50 8.88 5.50 
Copepoda + 
Napulii 11.25
a
 12.00
a
 6.75
a,b
 4.00
b
 
Macro + Napulii 11.75
a
 11.75
a
 6.75
a,b
 3.75
b
 
Napulii 10.87
a
 12.00
a
 7.12
a,b
 4.00
b
 
 
 
 
Table 6 
 
Zooplankton biomass mean ranks for four creeks in four seasons.  There was no significant 
difference between any season (α = 0.1). 
 
Parameters Spring Summer  Fall Winter 
Total 9.75 11.75 8.00 4.50 
Macro 8.75 10.75 8.75 5.70 
Micro 10.00 12.50 6.75 4.75 
Cladocera 8.37 11.75 7.62 6.25 
Copepoda 9.50 9.75 8.75 6.00 
Copepoda  + 
Napulii 10.00 10.75 8.50 4.75 
Macro + Napulii 10.25 10.75 8.25 4.75 
Napulii 10.75 11.00 7.50 4.75 
 
 
 In the ANOVA of the six creek dataset, season had a significant effect on chitobiase 
activity (p = 0.086).  Although Tukey’s test, a fairly conservative multiple comparison procedure, 
did not indicate any significant difference among the mean ranks (Table 7).  Chitobiase activity 
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ranked means appeared greatest in the Fall (12.83) followed by Summer (8.16), Spring (8.16), 
and Winter (7.5). Biotic factor for six creeks over three seasons showed significant differences 
when biomass and abundance was analyzed (p < 0.1) (Table 7, 8).  Biomass was significantly 
different for macro, micro, copepoda combined with napulii, macro combined with napulii, and 
napulii individual samples (p < 0.1).  The trend of Summer samples being significantly different 
then winter but Fall being similar to both Summer and Winter was observed for all of these biotic 
groups (Table 7).  This same trend was observed for biotic grouping of total abundance and 
micro abundance (Table 8) 
 
Table 7   
 
Chitobiase activity and zooplankton abundance mean ranks in (by season) for six creeks over 
three seasons.  Letters indicate significant difference in Tukey’s test groupings (α = 0.1).  All 
significant difference in groupings follow the pattern of Summer, Spring, Fall,  
Winter for biotic factors. 
 
Parameters Summer  Fall Winter 
Chitobiase 8.16 12.83 7.50 
Total 13.83 7.83 6.83 
Macro 13.67
a
 9.83
a,b
 5.00
b
 
Micro 14.00
a
 8.50
a,b
 6.00
b
 
Cladocera 13.33
a
 9.5
a,b
 5.66
b
 
Copepoda 12.08 9.83 6.58 
Copepoda + 
Napulii 13.33
a
 9.33
a,b
 5.83
b
 
Macro + Napulii 13.50
a
 9.83
a,b
 5.16
b
 
Napulii 13.25
a
 9.08
a,b
 6.16
b
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Table 8 
 
Zooplankton biomass in regard to season for six creeks over three seasons.  Letters indicate 
significant difference in Tukey’s test groupings of ranked means (α = 0.1).  All significant 
difference in groupings follow the pattern of Summer, Spring, Fall, Winter for biotic factors. 
 
Parameters Summer  Fall Winter 
Chitobiase 8.16 12.83 7.50 
Total 13.16
a
 8.83
a,b
 6.50
b
 
Macro 12.66 9.33 6.50 
Micro 13.33
a
 8.33
a,b
 6.83
b
 
Cladocera 12.83 8.33 7.33 
Copepoda 11.33 9.66 7.50 
Copeopda + 
Napulii 12.00 9.66 6.83 
Macro + Napulii 12.50 9.33 6.66 
Napulii 12.30 9.00 7.16 
 
 
Ambient chitobiase activity ranged from a low of 0.517 µmol·L
-1
·h
-1
 in the Soddy Creek 
Fall sample to a high of 1.515 µmol·L
-1
·h
-1 
in the Candies Creek fall sample (Table 9).  Total 
zooplankton abundance ranged from 0.95 ind./L to 4927.51 ind./L throughout the sampling 
period (Table 10).  Macro zooplankton abundance were low for all creeks during all seasons with 
the largest sample taken at Wolftever during the spring, containing 4.51 ind./L (Table 10).  Micro 
zooplankton abundance ranged from 0.94 ind./L taken during the winter on Soddy Creek to 
1589.88 ind./L taken from the same creek during the Summer (Table 10).  A partial list of the 
most abundant taxa can be found in Table 11.  A complete list of taxa is found in Appendix A.  
The most common species found throughout the samples was the rotifer Polyartha vulgaris, 
observed a total of 646 times.  In the samples collected, rotifers were found to outnumber 
copepods 17.7:1 and cladocerans 13529.9:1.  Cyclopoid copepodid was the most common 
copepod observed, a total of 648 times.  Appendix A includes a complete list of taxa.   
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Table 9 
 
Chitobiase activity detected for all creeks and seasons.  Chitobiase activity is expressed as 
µmol·L
-1
·h
-1
. Sequatchie and Candies Creek were not sampled in the Spring. 
 
  Spring Summer  Fall Winter 
North Chickamauga 1.233 0.670 0.980 0.568 
South Chickamauga 0.609 0.517 1.067 1.284 
Soddy 0.786 0.850 0.587 0.301 
Wolftever 0.991 0.808 1.024 0.736 
Sequatchie n/a 0.507 0.930 0.446 
Candies n/a 1.107 1.515 0.938 
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Table 10 
 
Abundance and biomass for zooplankton samples collected over one year for creeks.  Rotifers 
showed the largest abundance among groups.  Biomass is presented as µg of dry weight per liter. 
 
   
Total 
Abundance 
(Ind./L) 
Total 
Biomass 
(µg/L) 
Macro 
Abundance 
(Ind./L) 
Macro 
Biomass 
(µg/L) 
Micro 
Abundance 
(Ind./L) 
Micro 
Biomass 
(µg/L) 
North Spring 6.367 0.253 0.033 0.025 6.333 0.228 
Chickamauga  Summer 37.678 0.726 0.511 0.284 37.167 0.441 
 Fall 51.151 2.027 1.373 1.191 49.778 0.836 
 Winter 1.033 0.063 0.033 0.047 1.000 0.016 
        
South Spring 1.944 0.053 0.000 0.000 1.944 0.053 
Chickamauga Summer 145.033 2.088 0.200 0.080 144.833 2.008 
 Fall 6.922 0.332 0.311 0.195 6.611 0.137 
 Winter 2.656 0.157 0.044 0.043 2.611 0.114 
        
Soddy Spring 418.919 31.015 3.641 27.842 415.278 3.173 
 Summer 1590.744 17.040 0.856 2.516 1589.889 14.524 
 Fall 6.494 0.131 0.106 0.027 6.389 0.105 
 Winter 0.950 0.029 0.006 0.008 0.944 0.021 
        
Wolftever Spring 4927.512 52.183 4.512 3.051 4923.000 49.133 
 Summer 902.856 14.743 0.856 2.516 902.000 12.227 
 Fall 3.522 1.271 0.078 1.175 3.444 0.096 
 Winter 26.733 1.152 0.244 0.419 26.489 0.733 
        
Sequatchie Summer 421.106 18.905 2.578 1.507 418.528 17.398 
 Fall 2.117 0.901 0.506 0.633 1.611 0.268 
 Winter 26.500 0.777 0.011 0.045 26.489 0.733 
        
Candies Summer 2.550 0.105 0.161 0.050 2.389 0.056 
 Fall 5.861 0.096 0.028 0.011 5.833 0.085 
  Winter 10.589 0.501 0.089 0.408 10.500 0.093 
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Table 11 
 
List of most abundant zooplankton found in six 4
th
-6
th
 order tributaries of the Tennessee River in 
southeast Tennessee. 
 
Creek Division Genus species ind/L 
Candies Cladocera Alona rectangula 0.6 
 
Rotifera Anuraeopsis fissa 697.8 
 
Rotifera Bdelloid 4.4 
    North  Cladocera Bosmina longirostris 2.5 
Chickamauga Rotifera Collotheca 
7.7 
 
 
Rotifera Collurella 665.3 
 
Rotifera Conochiloides dossuarius 66.2 
 
Rotifera Conochilus unicornis 149.8 
    Sequatchie Copepoda Calanoid copepodid 1.0 
 
Rotifera Keratella cochlearis 118.2 
    
    Soddy Copepoda Cyclopoid copepodid 13.2 
 
Rotifera Keratella cochlearis 892 
 
Rotifera Limnias 133.8 
    South  Cladocera Diaphanosoma brachyurum 0.6 
Chickamauga Copepoda Epischura fluviatilis 2.4 
 
Cladocera Cladoceran immature 0.9 
 
Copepoda Napulii 441.5 
 
Rotifera Polyarthra vulgaris 697.5 
    Wolftever Ostracoda Ostracod 0.3 
  Rotifera Polyarthra vulgaris 567.2 
 
 
Discussion 
In lotic systems, such as those in the present study, water residence time is lower than that 
in lentic systems; therefore riverine zooplankton populations are typically dominated by rotifers 
and other taxa that require shorter generation times (i.e. time to reach sexually maturity) (Basu & 
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Pick, 1996).  Zooplankton with longer generation times, such as cladocerans and to some extent 
copepods, are susceptible to advection-related declines in local population density in riverine 
systems due to the short water residence time (Pace, Findlay, & Lints, 1992).  The abundance of 
zooplankton observed in the current study (rotifers > nauplii > copepods > cladocerans) 
corresponds with previous literature on river zooplankton community structure (Basu & Pick, 
1996; Pace et al., 1992; Thorp, Black, Haag, & Wehr, 1994).  
The creeks in the current study are large enough to support a zooplankton population 
(Gliwicz, 2002; Gosselain et al., 1998; Thorp & Delong, 2002).  However, benthic invertebrates 
generally make up a large proportion of aquatic invertebrate assemblages in 4
th
-6
th
 order creeks 
and were not accounted for in this study.  Indeed, a majority of biodiversity in lotic systems can 
be attributed to benthic macroinvertebrates, most of which release chitobiase (Heino, 2005).  
Because no benthic macroinvertebrates were assessed, the effect of that population on chitobiase 
concentrations in the water column is unknown.    
Lentic systems have been shown to support larger populations of zooplankton than lotic 
systems (Bradt, Urban, Goodman, Bissell, & Spiegel, 1999).  Which may contribute more 
significantly to total ambient chitobiase activity future studies should be conducted to evaluate 
possible correlations between zooplankton population dynamics and ambient chitobiase activity. 
There was no statistical between season differences in the mean ranks of ambient 
chitobiase activity; however, the amount of chitobiase activity appeared to be relatively high in 
the Fall and low in the Winter.  Conley et al. (2009) found the same seasonal pattern of 
chitobiase activity levels in the upper Tennessee River (p<0.05).  The fact that no significant 
difference was found in the present study may be due to several factors.  First, the sample size in 
the present study (n=6) is half that of Conley et al. (2009).  Second, the Tennessee River is a 8
th
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order river that is regulated by dams that control the volume of water throughout all seasons.  
Seasonal fluctuation of creek volume created by river stage manipulation and natural rainfall 
patterns was observed for all creeks in the study.  For example, Candies Creek and Wolftever 
Creek both had drastic fluctuation in volume throughout the sampling periods.  Ambient 
chitobiase activity in the water column is susceptible to seasonal water level dilution as well as 
the amount of arthropods molting.  Therefore, lower amounts of water could contribute to higher 
measurements of chitobiase activity even though there is a lower arthropod population.  Lastly, 
chitobiase degradation rates were not measured.  Oosterhuis et al. (2000) found that decay of 
chitobiase caused by bacteria varied with seasons and also was not necessarily dependent on the 
amount of bacteria present culture in a in situ study.  These degradation rates are important when 
trying to link chitobiase activity to secondary production (Oosterhuis et al., 2000).    
Arthropod communities have shown an increase in abundance for more tolerant species 
and decrease in less tolerant species when certain pollutants have contaminated the aquatic 
environment (Bradt et al., 1999; Reice, 1994; Richards et al., 2004).  In these cases chitobiase 
activity would not be useful in reflecting this type of change in the arthropod community.  In 
addition, long term monitoring is needed to determine averages and inconsistency in aquatic 
environments (Likens & Lambert, 1998).  Accordingly, for ambient chitobiase activity to be used 
as a monitoring tool, chitobiase samples would have to be taken over a long period of time.  This 
would allow for a pattern to emerge that would indicate anomalies.  However, data from the 
present study do not support the use of ambient chitobiase as an indicator of water-column 
zooplankton community health, growth, or abundance.  
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CHAPTER IV 
 
CONCLUSION 
 
  
 This thesis presented the concerns and alternatives to aquatic toxicology and monitoring.  
In the first study, D. magna were exposed to a mixture of pharmaceuticals that was detected in 
the Tennessee River in order to investigate what concentration would cause a toxic effect.  The 
second study attempted to find a correlation between zooplankton population dynamics and a 
molting enzyme, called chitobiase, to develop a quick and simple assay to monitor invertebrate 
production in freshwater environments.  Both studies were preformed in order to assist in closing 
current knowledge gaps concerning relevant ecotoxicological issues.   
 The chronic 21-d assays was chosen to evaluate the effects of the pharmaceutical cocktail 
found in the Tennessee River on D. magna to asses toxic effects over the course of the organism's 
life cycle.  These types of tests are the most relevant to exposure scenarios in the environment. 
Indeed, pharmaceuticals are in the aquatic environment in complex mixtures and organisms are 
exposed to these pollutants over the course of their entire life.  That study found that the mixture 
would have to be 100 times greater than what is currently detected, with all pharmaceuticals 
being at their maximum concentration, before reproduction would be significantly reduced.  
Currently, the FDA does not require pharmaceuticals to undergo chronic mixture toxicity tests 
before approval and some may be exempt from chronic assays altogether.  Studies, such as the 
one presented in Chapter I, illustrated that mixtures of pharmaceuticals can result in toxic effects 
that are below the NOEC for any single pharmaceutical.  Future studies should continue to focus 
on environmentally relative mixtures and chronic exposures to evaluate the hazard.   
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 The monitoring of aquatic environments can be very time consuming and costly.  Current 
practices of assessing invertebrates to evaluate aquatic system health often take months and are 
labor intensive.  The second study presented examined whether the monitoring of ambient 
aquatic chitobiase could determine zooplankton population health in 4
th
-6
th
 order streams.  The 
results from this study showed no relationship. This is due in part because no significant 
difference in chitobiase activity between seasons was found.  However, other work indicates that 
chitobiase still shows promise as an indicator of secondary production when degradation rates of 
the enzyme are known.  
Increased awareness and research on pharmaceuticals released into the environment is the 
first step to truly understanding the impact that such compounds have on the aquatic 
environment.  The development of novel endpoints that can be used on a river system level 
would aid in the monitoring of the potential ecological consequences of these compounds.   
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Table 12 
 
Complete list of taxa for each creek with number of individuals per liter (ind./L) and species biomass expressed as micrograms of dry 
weight per liter ((µg d.w.)/L). 
Site Name 
Sample 
Type 
Season Division Genus  species ind. / L   
species biomass  
((µg d.w.)/L)  
North  Macro Spring Cladocera Alona rectangula 0.006 0.000 
Chickamauga Macro Spring Cladocera Bosmina longirostris 0.006 0.002 
Creek Macro Spring Copepoda Calanoid copepodid 0.006 0.005 
 
Macro Spring Copepoda Cyclopoid copepodid 0.011 0.010 
 
Macro Spring Copepoda Paracyclops chiltoni 0.006 0.008 
  
 
     North  Macro Summer Cladocera Alona rectangula 0.317 0.030 
Chickamauga Macro Summer Cladocera Bosmina longirostris 0.022 0.031 
Creek Macro Summer Cladocera Bosminopsis deitersi 0.083 0.133 
 
Macro Summer Cladocera Pleuroxus spp. 0.022 0.003 
 
Macro Summer Copepoda Cyclopoid copepodid 0.056 0.051 
 
Macro Summer Copepoda Epischura fluviatilis 0.006 0.031 
 
Macro Summer Copepoda Tropocyclops prasinus 0.006 0.006 
  
 
     North  Macro Fall Cladocera Bosmina longirostris 1.127 0.978 
Chickamauga Macro Fall Cladocera Ceriodaphnia spp. 0.020 0.019 
Creek Macro Fall Cladocera Daphnia ambigua 0.020 0.032 
 
Macro Fall Cladocera Diaphanosoma brachyurum 0.007 0.002 
 
Macro Fall Cladocera Kurzia  latissima 0.007 0.001 
 
Macro Fall Copepoda Calanoid copepodid 0.127 0.113 
 
Macro Fall Copepoda Cyclopoid copepodid 0.060 0.026 
 
Macro Fall Copepoda Eurytemora affinis 0.007 0.020 
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Table 12 cont. 
   
Site Name 
Sample 
Type 
Season Division Genus  species ind. / L   
species biomass  
((µg d.w.)/L)  
North  Macro Winter Cladocera Bosmina longirostris 0.022 0.025 
Chickamauga Macro Winter Cladocera Bosminopsis deitersi 0.006 0.013 
Creek Macro Winter Cladocera Chydorus  sphaericus 0.006 0.009 
  
 
     South Macro Spring N/A No Zooplankton  
 
N/A N/A 
Chickamauga 
 
 
 
Observed 
   Creek Macro Summer Cladocera Alona rectangula 0.133 0.006 
 
Macro Summer Cladocera Bosminopsis deitersi 0.044 0.059 
 
Macro Summer Cladocera immature Cladoceran 0.006 0.004 
 
Macro Summer Copepoda Cyclopoid copepodid 0.011 0.005 
 
Macro Summer Copepoda Tropocyclops prasinus 0.006 0.006 
  
 
     South Macro Fall Cladocera Alona guttata 0.006 0.000 
Chickamauga Macro Fall Cladocera Alona rectangula 0.011 0.001 
Creek Macro Fall Cladocera Bosmina longirostris 0.217 0.158 
 
Macro Fall Cladocera Chydorus  sphaericus 0.011 0.006 
 
Macro Fall Cladocera Kurzia  latissima 0.006 0.001 
 
Macro Fall Ostracoda OSTRACOD 
 
0.022 0.006 
 
Macro Fall Copepoda Calanoid copepodid 0.011 0.019 
 
Macro Fall Copepoda Cyclopoid copepodid 0.028 0.004 
  
 
     South Macro Winter Cladocera Alona rectangula 0.011 0.001 
Chickamauga Macro Winter Cladocera Bosmina longirostris 0.006 0.004 
Creek Macro Winter Copepoda Calanoid copepodid 0.006 0.016 
 
Macro Winter Copepoda Cyclopoid copepodid 0.006 0.003 
 
Macro Winter Copepoda Tropocyclops prasinus 0.017 0.019 
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Site Name 
Sample 
Type 
Season Division Genus  species ind. / L   
species biomass  
((µg d.w.)/L)  
Candies Macro Fall Ostracoda OSTRACOD 
 
0.011 0.001 
Creek Macro Fall Copepoda Cyclopoid copepodid 0.017 0.010 
  
 
     Candies Macro Summer Cladocera Bosmina longirostris 0.139 0.040 
Creek Macro Summer Cladocera Bosminopsis deitersi 0.006 0.003 
 
Macro Summer Cladocera Ilyocryptus spp. 0.006 0.000 
 
Macro Summer Copepoda Calanoid copepodid 0.006 0.006 
 
Macro Summer Copepoda Cyclopoid copepodid 0.006 0.001 
  
 
     Candies Macro Summer Cladocera Bosmina longirostris 0.139 0.040 
Candies Macro Winter Cladocera Alona rectangula 0.017 0.002 
Creek Macro Winter Cladocera Bosmina longirostris 0.006 0.004 
 
Macro Winter Cladocera Chydorus  sphaericus 0.011 0.021 
 
Macro Winter Copepoda Cyclopoid copepodid 0.044 0.370 
 
Macro Winter Copepoda Tropocyclops prasinus 0.011 0.011 
  
 
     Soddy Creek Macro Spring Cladocera Bosmina longirostris 0.145 0.042 
 
Macro Spring Cladocera Chydorus  sphaericus 0.048 0.031 
 
Macro Spring Cladocera Holopedium gibberum 0.097 17.065 
 
Macro Spring Cladocera Sida crystallina 0.016 0.019 
 
Macro Spring Cladocera immature Cladoceran 0.161 0.102 
 
Macro Spring Ostracoda OSTRACOD 
 
0.016 0.001 
 
Macro Spring Copepoda Calanoid copepodid 0.628 0.452 
 
Macro Spring Copepoda Cyclopoid copepodid 0.129 0.049 
 
Macro Spring Copepoda Epischura fluviatilis 2.401 10.081 
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Table 12 cont. 
   
Site Name 
Sample 
Type 
Season Division Genus  species ind. / L   
species biomass  
((µg d.w.)/L)  
Soddy  Macro Summer Cladocera Bosmina longirostris 0.117 0.099 
Creek Macro Summer Cladocera Bosminopsis deitersi 0.039 0.060 
 
Macro Summer Cladocera Macrothrix  rosea 0.117 0.018 
 
Macro Summer Cladocera Sida crystallina 0.078 0.267 
 
Macro Summer Cladocera Simocephalus  serrulatus 0.039 1.757 
 
Macro Summer Ostracoda OSTRACOD 
 
0.078 0.042 
 
Macro Summer Copepoda Calanoid copepodid 0.039 0.060 
 
Macro Summer Copepoda Cyclopoid copepodid 0.311 0.173 
 
Macro Summer Copepoda Tropocyclops prasinus 0.039 0.040 
  
 
     Soddy  Macro Fall Cladocera Alona rectangula 0.083 0.006 
Creek Macro Fall Copepoda Cyclopoid copepodid 0.022 0.021 
  
 
     Soddy Creek Macro Winter Cladocera Chydorus  sphaericus 0.006 0.008 
  
 
     Sequatchie Macro Summer Cladocera Bosmina longirostris 0.114 0.119 
River Macro Summer Cladocera Ceriodaphnia spp. 0.159 0.141 
 
Macro Summer Cladocera Diaphanosoma brachyurum 0.568 0.112 
 
Macro Summer Cladocera Ilyocryptus spp. 0.011 0.000 
 
Macro Summer Cladocera Simocephalus  serrulatus 0.011 0.405 
 
Macro Summer Cladocera immature Cladoceran 0.659 0.166 
 
Macro Summer Copepoda Cyclopoid copepodid 0.988 0.441 
 
Macro Summer Copepoda Ergasilus spp. 0.045 0.055 
 
Macro Summer Copepoda Macrocyclops albidus 0.011 0.055 
 
Macro Summer Copepoda Tropocyclops prasinus 0.011 0.012 
  
 
     Sequatchie Macro Fall Cladocera Bosmina longirostris 0.444 0.351 
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Site Name 
Sample 
Type 
Season Division Genus  species ind. / L   
species biomass  
((µg d.w.)/L)  
Sequatchie Macro Fall Cladocera Bosminopsis deitersi 0.017 0.013 
River Macro Fall Cladocera Simocephalus  vetulus 0.017 0.246 
 
Macro Fall Copepoda Cyclopoid copepodid 0.028 0.023 
  
 
     Sequatchie Macro Winter Cladocera Camptocercus spp. 0.006 0.039 
River Macro Winter Copepoda Tropocyclops prasinus 0.006 0.005 
  
 
     Wolftever  Macro Spring Cladocera Bosmina longirostris 0.017 0.012 
Creek Macro Spring Cladocera Ceriodaphnia spp. 0.017 0.011 
 
Macro Spring Cladocera Chydorus  sphaericus 0.086 0.024 
 
Macro Spring Cladocera Daphnia ambigua 0.138 0.171 
 
Macro Spring Cladocera Diaphanosoma brachyurum 0.017 0.021 
Wolftever  Macro Spring Cladocera Eurycercus spp. 0.017 0.013 
Creek Macro Spring Cladocera Simocephalus  serrulatus 0.017 0.033 
 
Macro Spring Cladocera immature Cladoceran 0.121 0.031 
 
Macro Spring Ostracoda OSTRACOD 
 
0.172 0.014 
 
Macro Spring Copepoda Calanoid copepodid 0.224 0.311 
 
Macro Spring Copepoda Cyclopoid copepodid 3.358 1.837 
 
Macro Spring Copepoda Ergasilus spp. 0.034 0.006 
 
Macro Spring Copepoda Harpacticoid 
 
0.017 0.012 
 
Macro Spring Copepoda Mesocyclops edax 0.155 0.259 
 
Macro Spring Copepoda Skistodiaptomus pallidus 0.121 0.297 
  
 
     Wolftever  Macro Summer Cladocera Bosmina longirostris 0.100 0.113 
Creek Macro Summer Cladocera Ceriodaphnia spp. 0.067 0.171 
 
Macro Summer Copepoda Cyclopoid copepodid 8.100 4.948 
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Site Name 
Sample 
Type 
Season Division Genus  species ind. / L   
species biomass  
((µg d.w.)/L)  
Wolftever  Macro Fall Copepoda Cyclopoid copepodid 0.022 0.014 
Creek Macro Fall Copepoda Macrocyclops albidus 0.056 1.162 
        Wolftever  Macro Winter Cladocera Alona guttata 0.006 0.000 
Creek Macro Winter Cladocera Alona rectangula 0.006 0.003 
 
Macro Winter Cladocera Bosmina longirostris 0.011 0.006 
 
Macro Winter Cladocera Daphnia ambigua 0.017 0.016 
 
Macro Winter Ostracoda OSTRACOD 
 
0.017 0.030 
 
Macro Winter Copepoda Calanoid copepodid 0.122 0.271 
 
Macro Winter Copepoda Cyclopoid copepodid 0.017 0.018 
 
Macro Winter Copepoda Skistodiaptomus reighardi 0.044 0.069 
 
Macro Winter Copepoda Tropocyclops prasinus 0.006 0.006 
  
 
     Candies Micro Summer Copepoda Nauplii _ 0.111 0.001 
Creek Micro Summer Rotifera Bdelloid 
 
0.111 0.018 
 
Micro Summer Rotifera Brachionus havanaensis 0.111 0.002 
 
Micro Summer Rotifera Keratella cochlearis 1.222 0.002 
  
 
     
 
Micro Summer Rotifera Keratella crassa 0.222 0.000 
 
Micro Summer Rotifera Lepadella spp. 0.111 0.000 
 
Micro Summer Rotifera Monommata spp. 0.111 0.001 
 
Micro Summer Rotifera Synchaeta spp. 0.167 0.001 
 
Micro Summer Rotifera Trichocerca multicrinis 0.056 0.004 
 
Micro Summer Rotifera Trichocerca spp. 0.056 0.000 
 
Micro Summer Rotifera unidentified rotifer 0.111 0.025 
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Table 12 cont. 
   
Site Name 
Sample 
Type 
Season Division Genus  species ind. / L   
species biomass  
((µg d.w.)/L)  
Candies Micro Fall Copepoda Nauplii 
 
0.444 0.008 
Creek Micro Fall Rotifera Bdelloid 
 
0.278 0.013 
 
Micro Fall Rotifera Dicranophorus spp. 0.056 0.004 
 
Micro Fall Rotifera Euchlanis meneta 0.111 0.011 
 
Micro Fall Rotifera Kellicottia longispina 0.056 0.000 
 
Micro Fall Rotifera Keratella cochlearis 0.111 0.000 
 
Micro Fall Rotifera Keratella crassa 1.000 0.004 
 
Micro Fall Rotifera Ploesoma truncatum 0.056 0.002 
 
Micro Fall Rotifera Synchaeta spp. 3.722 0.044 
        Candies Micro Winter Copepoda Nauplii 
 
0.500 0.024 
Creek Micro Winter Rotifera Anuraeopsis fissa 0.167 0.000 
 
Micro Winter Rotifera Collurella spp. 4.611 0.004 
 
Micro Winter Rotifera Keratella cochlearis 2.444 0.002 
 
Micro Winter Rotifera Keratella cochlearis f. tecta 0.056 0.000 
 
Micro Winter Rotifera Keratella crassa 0.278 0.001 
 
Micro Winter Rotifera Lepadella ovalis 0.111 0.001 
 
Micro Winter Rotifera Monommata spp. 0.056 0.000 
 
Micro Winter Rotifera Notholca acuminata 0.111 0.005 
Candies Micro Winter Rotifera Polyarthra major 0.056 0.003 
Creek Micro Winter Rotifera Polyarthra vulgaris 0.389 0.005 
 
Micro Winter Rotifera Proales spp. 0.167 0.017 
 
Micro Winter Rotifera Synchaeta spp. 1.556 0.030 
        Soddy  Micro Spring Copepoda Nauplii 
 
14.444 0.443 
Creek Micro Spring Rotifera Brachionus angularis 1.806 0.011 
 
Micro Spring Rotifera Brachionus havanaensis 9.028 0.060 
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Site Name 
Sample 
Type 
Season Division Genus  species ind. / L   
species biomass  
((µg d.w.)/L)  
Soddy  Micro Spring Rotifera Conochiloides dossuarius 9.028 0.272 
Creek Micro Spring Rotifera Conochilus unicornis 25.278 0.409 
 
Micro Spring Rotifera Kellicottia longispina 3.611 0.024 
 
Micro Spring Rotifera Keratella cochlearis 99.306 0.087 
 
Micro Spring Rotifera Keratella cochlearis f. tecta 90.278 0.064 
 
Micro Spring Rotifera Keratella crassa 137.222 0.609 
 
Micro Spring Rotifera Polyarthra vulgaris 18.056 0.425 
 
Micro Spring Rotifera Trichocerca iernis 7.222 0.769 
        Soddy  Micro Summer Copepoda Nauplii 
 
59.222 3.931 
Creek Micro Summer Rotifera Anuraeopsis fissa 13.667 0.007 
 
Micro Summer Rotifera Collurella spp. 646.889 0.344 
 
Micro Summer Rotifera Filinia longiseta 9.111 0.225 
 
Micro Summer Rotifera Hexarthra mira 18.222 0.334 
 
Micro Summer Rotifera Keratella americana 27.333 0.046 
 
Micro Summer Rotifera Keratella cochlearis 195.889 0.162 
 
Micro Summer Rotifera Polyarthra vulgaris 496.556 7.466 
 
Micro Summer Rotifera Synchaeta spp. 95.667 1.824 
 
Micro Summer Rotifera Trichocerca pusilla 18.222 0.112 
 
Micro Summer Rotifera Trichocerca similis 9.111 0.074 
        Soddy  Micro Fall Copepoda Nauplii _ 0.556 0.012 
Creek Micro Fall Rotifera Bdelloid 
 
0.556 0.004 
 
Micro Fall Rotifera Collurella spp. 0.833 0.001 
 
Micro Fall Rotifera Keratella cochlearis 1.111 0.001 
 
Micro Fall Rotifera Keratella cochlearis f. tecta 0.278 0.000 
 
Micro Fall Rotifera Keratella earlinae 0.278 0.001 
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Site Name 
Sample 
Type 
Season Division Genus  species ind. / L   
species biomass  
((µg d.w.)/L)  
Soddy  Micro Fall Rotifera Trichocerca similis 0.833 0.040 
Creek Micro Fall Rotifera Trichotria tetractis 0.278 0.015 
 
Micro Fall Rotifera unidentified rotifer 0.278 0.002 
 
Micro Fall Bivalvia unidentified veliger 0.278 0.006 
 
Micro Fall Rotifera Lecane inermis 1.111 0.021 
        Soddy  Micro Winter Copepoda Nauplii _ 0.111 0.002 
Creek Micro Winter Rotifera Bdelloid 
 
0.167 0.003 
 
Micro Winter Rotifera Cephalodella spp. 0.167 0.004 
 
Micro Winter Rotifera Collotheca spp. 0.056 0.001 
 
Micro Winter Rotifera Keratella cochlearis 0.167 0.000 
 
Micro Winter Rotifera Notholca acuminata 0.111 0.003 
 
Micro Winter Rotifera Polyarthra vulgaris 0.056 0.002 
 
Micro Winter Rotifera Proales spp. 0.111 0.005 
        North  Micro Spring Copepoda Nauplii _ 1.667 0.202 
Chickamauga Micro Spring Rotifera Brachionus caudatus 0.500 0.006 
Creek Micro Spring Rotifera Brachionus havanaensis 0.167 0.004 
 
Micro Spring Rotifera Kellicottia longispina 0.167 0.001 
 
Micro Spring Rotifera Keratella cochlearis 1.000 0.001 
 
Micro Spring Rotifera Keratella cochlearis f. tecta 1.833 0.002 
 
Micro Spring Rotifera Keratella crassa 0.500 0.002 
 
Micro Spring Rotifera Synchaeta spp. 0.500 0.011 
North  Micro Summer Copepoda Nauplii _ 3.333 0.099 
Chickamauga Micro Summer Rotifera Conochiloides dossuarius 2.833 0.069 
Creek Micro Summer Rotifera Conochilus unicornis 2.667 0.008 
 
Micro Summer Rotifera Keratella cochlearis 0.667 0.000 
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Site Name 
Sample 
Type 
Season Division Genus  species ind. / L   
species biomass  
((µg d.w.)/L)  
North  Micro Summer Rotifera Platyias quadricornus 0.333 0.005 
Chickamauga Micro Summer Rotifera Polyarthra vulgaris 23.000 0.253 
 
Micro Summer Rotifera Keratella cochlearis f. tecta 4.167 0.004 
 
Micro Summer Rotifera Lecane spp. 0.167 0.002 
        North  Micro Fall Copepoda Nauplii _ 6.000 0.463 
Chickamauga Micro Fall Rotifera Anuraeopsis fissa 0.222 0.000 
Creek Micro Fall Rotifera Bdelloid 
 
2.444 0.077 
 
Micro Fall Rotifera Cephalodella spp. 0.444 0.006 
 
Micro Fall Rotifera Kellicottia longispina 0.222 0.001 
 
Micro Fall Rotifera Keratella cochlearis 13.111 0.011 
 
Micro Fall Rotifera Keratella cochlearis f. tecta 7.778 0.006 
 
Micro Fall Rotifera Keratella crassa 0.444 0.001 
 
Micro Fall Rotifera Lepadella spp. 0.222 0.001 
 
Micro Fall Rotifera Monommata spp. 0.222 0.001 
 
Micro Fall Rotifera Ploesoma truncatum 0.667 0.033 
 
Micro Fall Rotifera Polyarthra vulgaris 7.333 0.120 
 
Micro Fall Rotifera Synchaeta spp. 10.444 0.112 
 
Micro Fall Rotifera Trichocerca iernis 0.222 0.004 
        North  Micro Winter Copepoda Nauplii _ 0.167 0.015 
Chickamauga Micro Winter Rotifera Collurella spp. 0.333 0.000 
Creek Micro Winter Rotifera Keratella cochlearis 0.333 0.001 
 
Micro Winter Rotifera Keratella cochlearis f. tecta 0.167 0.000 
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Site Name 
Sample 
Type 
Season Division Genus  species ind. / L   
species biomass  
((µg d.w.)/L)  
South Micro Spring Copepoda Nauplii _ 0.778 0.043 
Chickamauga Micro Spring Rotifera Keratella cochlearis f. tecta 0.611 0.001 
Creek Micro Spring Rotifera Proales spp. 0.278 0.004 
 
Micro Spring Rotifera unidentified rotifer 0.278 0.005 
South Micro Spring Copepoda Nauplii _ 0.778 0.043 
Chickamauga Micro Spring Rotifera Keratella cochlearis f. tecta 0.611 0.001 
South Micro Summer Copepoda Nauplii _ 1.222 0.026 
Chickamauga Micro Summer Rotifera Anuraeopsis fissa 14.056 0.015 
Creek Micro Summer Rotifera Cephalodella spp. 4.889 0.053 
 
Micro Summer Rotifera Collurella spp. 1.833 0.002 
 
Micro Summer Rotifera Conochiloides dossuarius 9.778 0.143 
 
Micro Summer Rotifera Conochilus unicornis 2.444 0.030 
 
Micro Summer Rotifera Filinia longiseta 3.056 0.099 
 
Micro Summer Rotifera Keratella cochlearis 2.444 0.003 
 
Micro Summer Rotifera Keratella cochlearis f. tecta 10.389 0.011 
 
Micro Summer Rotifera Keratella crassa 1.222 0.005 
 
Micro Summer Rotifera Lecane leontina 0.611 0.028 
 
Micro Summer Rotifera Lecane spp. 0.611 0.002 
 
Micro Summer Rotifera Polyarthra major 6.722 0.414 
 
Micro Summer Rotifera Polyarthra vulgaris 69.056 1.019 
 
Micro Summer Rotifera Proales spp. 0.611 0.059 
 
Micro Summer Rotifera Trichocerca rousseleti 13.444 0.070 
 
Micro Summer Rotifera Trichocerca similis 2.444 0.029 
        South Micro Fall Copepoda Nauplii _ 0.778 0.065 
Chickamauga Micro Fall Rotifera Cephalodella spp. 0.056 0.002 
Creek Micro Fall Rotifera Collurella spp. 0.056 0.000 
  
 
     
72 
 
  
 
 
Table 12 cont. 
   
Site Name 
Sample 
Type 
Season Division Genus  species ind. / L   
species biomass  
((µg d.w.)/L)  
South Micro Fall Rotifera Euchlanis meneta 0.167 0.025 
Chickamauga Micro Fall Rotifera Keratella americana 0.111 0.000 
Creek Micro Fall Rotifera Keratella cochlearis 1.000 0.001 
 
Micro Fall Rotifera Keratella cochlearis f. tecta 0.611 0.001 
 
Micro Fall Rotifera Keratella crassa 2.000 0.006 
 
Micro Fall Rotifera Lecane luna 0.056 0.001 
 
Micro Fall Rotifera Lepadella spp. 0.056 0.000 
 
Micro Fall Rotifera Monostyla quadridentata 0.056 0.001 
 
Micro Fall Rotifera Polyarthra major 0.111 0.008 
 
Micro Fall Rotifera Polyarthra vulgaris 0.222 0.004 
 
Micro Fall Rotifera Synchaeta spp. 1.333 0.023 
        South Micro Winter Copepoda Nauplii _ 0.333 0.023 
Chickamauga Micro Winter Rotifera Cephalodella spp. 0.111 0.006 
Creek Micro Winter Rotifera Collurella spp. 0.389 0.000 
 
Micro Winter Rotifera Euchlanis spp. 0.056 0.002 
 
Micro Winter Rotifera Kellicottia bostoniensis 0.056 0.000 
 
Micro Winter Rotifera Keratella cochlearis 0.111 0.000 
 
Micro Winter Rotifera Keratella earlinae 0.389 0.001 
 
Micro Winter Rotifera Notholca acuminata 0.056 0.002 
 
Micro Winter Rotifera Proales spp. 0.444 0.065 
 
Micro Winter Rotifera Trichotria tetractis 0.056 0.001 
 
Micro Winter Rotifera unidentified rotifer 0.611 0.014 
        Sequatchie Micro Summer Copepoda Nauplii _ 15.250 0.330 
 River Micro Summer Rotifera Anuraeopsis fissa 18.639 0.019 
 
Micro Summer Rotifera Asplanchna priodonta 8.472 3.500 
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Table 12 cont. 
   
Site Name 
Sample 
Type 
Season Division Genus  species ind. / L   
species biomass  
((µg d.w.)/L)  
Sequatchie Micro Summer Rotifera Brachionus angularis 27.111 0.251 
 River Micro Summer Rotifera Brachionus havanaensis 25.417 0.170 
 
Micro Summer Rotifera Conochiloides dossuarius 5.083 0.064 
 
Micro Summer Rotifera Conochilus unicornis 13.556 0.177 
 
Micro Summer Rotifera Keratella cochlearis 1.694 0.001 
 
Micro Summer Rotifera Limnias sp. 133.861 10.369 
 
Micro Summer Rotifera Monostyla quadridentata 13.556 0.258 
 
Micro Summer Rotifera Polyarthra vulgaris 83.028 1.463 
 
Micro Summer Rotifera Synchaeta spp. 52.528 0.538 
 
Micro Summer Rotifera Trichocerca pusilla 5.083 0.018 
 
Micro Summer Rotifera Trichocerca similis 15.250 0.240 
        Sequatchie Micro Fall Copepoda Nauplii _ 0.111 0.013 
 River Micro Fall Rotifera Bdelloid 
 
0.389 0.006 
 
Micro Fall Rotifera Euchlanis alata 0.056 0.001 
 
Micro Fall Rotifera Euchlanis meneta 0.278 0.231 
 
Micro Fall Rotifera Euchlanis spp. 0.278 0.013 
 
Micro Fall Rotifera Keratella cochlearis 0.111 0.000 
 
Micro Fall Rotifera Monostyla spp. 0.111 0.001 
 
Micro Fall Rotifera Synchaeta spp. 0.278 0.003 
        Sequatchie Micro Winter Copepoda Nauplii _ 0.111 0.002 
 River Micro Winter Rotifera Bdelloid 
 
0.222 0.010 
 
Micro Winter Rotifera Brachionus angularis 0.111 0.003 
 
Micro Winter Rotifera Collurella spp. 0.222 0.000 
 
Micro Winter Rotifera Keratella cochlearis 0.222 0.001 
 
Micro Winter Rotifera Keratella cochlearis f. tecta 0.111 0.000 
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Table 12 cont. 
   
Site Name 
Sample 
Type 
Season Division Genus  species ind. / L   
species biomass  
((µg d.w.)/L)  
Sequatchie Micro Winter Rotifera c.f. Lecane flexilis 0.111 0.001 
 River Micro Winter Rotifera Lecane inermis 0.111 0.001 
 
Micro Winter Rotifera Proales spp. 0.667 0.093 
 
Micro Winter Rotifera unidentified rotifer 0.222 0.001 
        Wolftever  Micro Spring Copepoda Nauplii _ 270.000 24.684 
Creek Micro Spring Rotifera Anuraeopsis fissa 387.000 0.457 
 
Micro Spring Rotifera Brachionus budapestinensis 18.000 0.335 
 
Micro Spring Rotifera Brachionus  forficula 99.000 0.918 
 
Micro Spring Rotifera Gastropus hyptopus 9.000 0.125 
 
Micro Spring Rotifera Keratella cochlearis 675.000 0.906 
 
Micro Spring Rotifera Keratella cochlearis f. tecta 2601.000 3.278 
 
Micro Spring Rotifera Lecane spp. 9.000 0.076 
 
Micro Spring Rotifera Polyarthra vulgaris 567.000 11.763 
 
Micro Spring Rotifera Proales spp. 9.000 1.217 
 
Micro Spring Rotifera Synchaeta spp. 108.000 3.716 
 
Micro Spring Rotifera Trichocerca spp. 54.000 0.367 
 
Micro Spring Rotifera unidentified rotifer 117.000 1.291 
        Wolftever  Micro Summer Copepoda Nauplii _ 63.556 5.830 
Creek Micro Summer Rotifera Anuraeopsis fissa 264.000 0.246 
 
Micro Summer Rotifera Brachionus bidentata 2.444 0.053 
 
Micro Summer Rotifera Brachionus calyciflorus 2.444 0.116 
 
Micro Summer Rotifera Brachionus  forficula 17.111 0.102 
 
Micro Summer Rotifera Collotheca spp. 2.444 0.051 
 
Micro Summer Rotifera Conochiloides dossuarius 39.111 0.771 
 
Micro Summer Rotifera Conochilus unicornis 105.111 1.009 
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Site Name 
Sample 
Type 
Season Division Genus  species ind. / L   
species biomass  
((µg d.w.)/L)  
Wolftever  Micro Summer Rotifera Filinia longiseta 2.444 0.060 
Creek Micro Summer Rotifera Keratella cochlearis 12.222 0.011 
 
Micro Summer Rotifera Monostyla quadridentata 4.889 0.122 
 
Micro Summer Rotifera Polyarthra vulgaris 312.889 3.392 
 
Micro Summer Rotifera Synchaeta spp. 22.000 0.124 
 
Micro Summer Rotifera Trichocerca rousseleti 14.667 0.030 
 
Micro Summer Rotifera Trichocerca similis 36.667 0.309 
        Wolftever  Micro Fall Copepoda Nauplii _ 1.000 0.071 
Creek Micro Fall Rotifera Bdelloid 
 
0.222 0.016 
 
Micro Fall Rotifera Keratella cochlearis 0.333 0.000 
 
Micro Fall Rotifera Keratella cochlearis f. tecta 0.222 0.000 
 
Micro Fall Rotifera Keratella crassa 1.333 0.004 
 
Micro Fall Rotifera unidentified rotifer 0.333 0.005 
        Wolftever  Micro Winter Copepoda Nauplii _ 1.778 0.252 
Creek Micro Winter Rotifera Cephalodella spp. 0.356 0.001 
 
Micro Winter Rotifera Collurella spp. 2.133 0.003 
 
Micro Winter Rotifera Conochiloides dossuarius 0.356 0.011 
 
Micro Winter Rotifera Encentrum spp. 0.444 0.043 
 
Micro Winter Rotifera Euchlanis alata 0.356 0.071 
 
Micro Winter Rotifera Keratella cochlearis 4.178 0.007 
 
Micro Winter Rotifera Lecane spp. 0.711 0.005 
 
Micro Winter Rotifera Lepadella spp. 0.356 0.002 
 
Micro Winter Rotifera Monostyla spp. 0.356 0.001 
 
Micro Winter Rotifera Notholca acuminata 0.711 0.018 
 
Micro Winter Rotifera Proales spp. 2.933 0.139 
 
Micro Winter Rotifera Synchaeta spp. 11.822 0.180 
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